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Introduction  
 
The report on the drug situation in Norway 2003 is based on collected data and written 
contributions from central public institutions and important players in the alcohol and drugs 
field in Norway. Part I was mainly written by the Ministry of Social Affairs. The external 
authors who contributed to parts II and III are mentioned under “co-authors”. The authors of 
part IV are listed under each specific topic.  
 
Most of the data in the report are from 2002. For seizures of narcotic substances and 
tendencies and trends, a summary has been included for the first six months of 2003.  
 
Odd Hordvin, the Focal Point’s senior advisor, has edited the report. An internal reference 
group in SIRUS, consisting of Director Knut Brofoss, Head of Research Sturla Nordlund, 
Advisor Hege C. Lauritzen, Researcher Astrid Skretting (scientific committee), Researcher 
Einar Ødegård and Advisor Marte K. Ødegård Lund, has commented on and approved the 
written contributions and the data.  
 
I would like to thank everyone, both at SIRUS as well as external partners, for their 
contributions.   
 
 
 
 
 
Oslo, November 2003 
 
 
Knut Brofoss 
Head of Focal Point   
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Summary 
 
Ø The most marked change in relation to 2001 is the strong reduction in the number of 
drug fatalities in 2002. Figures from the National Criminal Investigation Service show 
that 210 persons died as a consequence of narcotic substance abuse in 2002. This is 
almost 40% fewer than in 2001, when 338 such deaths were reported. The reduction 
may have several causes, including reduced heroin availability, less pure heroin, the 
fact that an increasing number of opiate users are in substitution treatment and the 
considerable increase in low threshold health services.  
Ø There was no demonstrable increase in the use of narcotic substances among young 
people between the ages of 15 and 20 from 2002 to 2003. SIRUS’ survey of 15-20 
year-olds for 2003 shows a marked increase in the use of alcohol, but no major 
changes from 2002 as regards the use of and attitudes to illicit drugs.  
Ø Various data sources and surveys show that drugs are being increasingly used and 
sold outside Oslo. There are hardly grounds for claiming that the number of young 
people at risk has increased, but the rural – urban constellation is in a process of 
change. Moreover, the socio-cultural dimension with increased availability of new 
substances in new milieus is a relatively clear trend viewed in a longer-term 
perspective. 
Ø An increasing number of drivers are caught driving under the influence of narcotic 
and medicinal drugs. The increase from 2001 to 2002 is much greater than any 
previously recorded – almost 20%. The samples taken reveal the presence of illicit 
drugs and a high proportion of medicinal drugs, particularly tranquillizers and sleeping 
pills. Figures showed a doubling in the incidence of Rohypnol.  
Ø At the same time we have seen a clear increase in the number of seizures of several 
of the most common illegal substances in 2001 and 2002. Figures for 2002 show that 
the biggest absolute increases were for benzodiazepines and amphetamines. Seized 
quantities of benzodiazepines also increased markedly, particularly the quantities of 
Rohypnol. 
Ø Figures for the first six months of 2003 show, however, a clear decrease in the 
number of drug cases and seizures. This applies to most substances, except LSD 
and GHB, and is particularly marked for ecstasy, benzodiazepines, cocaine and 
heroin. On the other hand, there have been many big seizures of most types of drugs.   
Ø In 2003 efforts to expand low threshold health services for heavy problem users have 
been intensified. There has again been a steep rise in the number of clients in 
medically assisted rehabilitation.  
 
Ø From 2002 ownership and operational responsibility for hospitals passed to the state. 
It is expected that also the counties’ responsibility for institutions and associated 
specialist services for the treatment of drug users will be transferred to the state from 
2004. A bill (Drugs and Alcohol Reform 2) is scheduled for consideration by the 
Storting in the autumn of 2003. The aim is to implement the reforms concurrently, with 
effect from 1 January 2004.  
Ø The Government’s new Action plan to combat alcohol and drug problems (2003-
2005) outlines strategically important goals for a policy on drugs and alcohol. As  part 
of the implementation two expert advisory committees were appointed in 2003 – one 
on alcohol and one on drugs. The committees are to provide the Government with 
ongoing advice about specific drug policy challenges, evaluate interventions, propose 
new ones and stimulate the development of more knowledge. 
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Ø On commission from the Minister of Social Affairs, a research commission has 
summarised existing knowledge on the effects of drug abuse prevention measures, 
identified a need for further research and pointed out political dilemmas and 
possibilities in this area in coming years. The commission submitted its report in 
February 2003. On the basis of this report, among other things, the Ministry of Social 
Affairs is now considering the future organisation of drug and alcohol-related research 
and the prioritisation of research topics. 
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Part I  NATIONAL STRATEGIES: INSTITUTIONAL & LEGAL 
FRAMEWORKS 
Chapter 1. Developments in Drug Policy and Responses 
1.1 Political framework in the drug field 
 
Objectives and priorities of national drug policy 
Norwegian drug policy is based on a comprehensive, multidisciplinary approach, in which 
prevention and treatment measures are balanced by concurrent measures aimed at control 
and supply reduction. Norway has pursued a restrictive drug policy ever since the use of 
drugs became a social problem among young people in the mid-1960s, banning both 
possession, non-medical use and sale of the substances in question.  
 
Important strategic objectives for the Government are to:  
 
· Reduce the supply of illegal narcotic substances  
· Reduce all illegal use of drugs 
· Increase the number of successful treatment forms for drug problems 
· Reduce morbidity and other social and health-related problems associated with drug 
abuse. 
 
Drug policy requires new modes of thinking in order to meet the dramatic increase in the 
availability and use of drugs that has taken place over the last decade. Increased 
experimentation, new narcotic substances and more users with extensive health and social 
problems require new solutions and an extension of those measures that have proven 
effective. Long-term, goal-oriented work is needed in order to reduce drug-related problems. 
 
New action plan 
On 3 October 2002 the Government proposed a new action plan to combat alcohol and drug 
problems, for the period 2003-2005. The challenges and strategic choices reflected in 
Norwegian drug policy are based on the following objectives: 
 
· Pursue a policy that both reduces alcohol and drug problems and is supported by the 
general population 
· Strengthen the municipalities’ and local communities’ preventive efforts, with 
particular emphasis on preventive and health-promoting initiatives aimed at children 
and adolescents in schools and in educational and leisure activities. 
· Ensure that problem users and their close families receive quality treatment and 
rehabilitation/follow-up so that the individuals concerned can live a dignified life. 
 
Through the action plan, the Government wishes to provide the basis for a broad-based 
strategy of effective measures that cover the entire alcohol and drugs field. The plan stresses 
the following specific target areas: 
 
· Integrated, locally-based measures to combat alcohol and drug use among children 
and young people, and alcohol and drug problems in general 
· Treatment and care for the most problematic users 
· Increased international cooperation 
· Improved coordination of efforts 
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· Knowledge production and quality assurance. 
 
 The use of illegal substances is in principle unacceptable both out of consideration for 
individuals and the society at large, and prevention work is based on this principle.  
 
A separate system for follow-up is being developed, consisting of annual performance 
targets, specific measures to be implemented within certain deadlines, and a system for 
evaluating target attainment. The action plan takes into account that developments may 
require changes and adjustments, for example as a result of the emergence of new narcotic 
substances.  
 
Treatment and rehabilitation of drug users 
The government is strengthening the treatment offered through redistribution of responsibility 
for measures to help drug users Particular emphasis is placed on strengthening the 
competence and efforts of the health-care services vis-à-vis this group. It also aims to ensure 
more comprehensive, individually adapted treatment alternatives, so that the clients avoid 
being passed from one agency to another in the area. 
Medically assisted rehabilitation for heavily dependent heroin users has been available 
nationally since 1998. National guidelines have been draw up concerning responsibility for 
and the organisation of medically assisted rehabilitation at regional and local levels. The 
system is based on specialised regional centres, but the municipal health and social services 
are responsible for follow-up. Experiences in this area are being evaluated. 
 
Reduction of Drug Related Harm 
A number of damage-reducing measures have been established for the most dependent 
problem users whereby continued use of drugs is accepted to a greater or lesser degree. 
Existing low-threshold health services for drug users have been strengthened through a 
significant increase in government grants. Low-threshold health services are important 
instruments in combating overdose fatalities. The services offered include health checks, 
vaccinations, the distribution of user equipment, protection against infectious diseases, 
guidance and follow-up after overdoses.  
 
A majority in the Storting has requested the government to facilitate trials with drug injection 
rooms. The government is drafting the required legislative amendments which will be put 
forward as soon as possible. 
 
Nordic and international cooperation 
Increased international cooperation is regarded as one of the most important factors if we are 
to succeed in reducing the availability of drugs in the years to come.  International 
cooperation - both at regional and global level - is considered one of the main elements of 
Norwegian drug policy, and is an important element in a comprehensive approach to fighting 
drug abuse. Since 1970 Norway has been an active participant in joint Nordic efforts aimed 
at combating drug problems, since 1979 through the Nordic Council of Ministers.  The joint 
Nordic effort includes cooperation between the police and customs authorities, research, 
continual exchange of information about the drug situation and related measures, 
coordination as far as possible of the countries’ views in international forums, and measures 
aimed at developing cooperation with neighbouring regions. At the European level, Norway is 
a member of the EMCDDA and the Council of Europe’s Pompidou Group. Norway has 
ratified the UN conventions on drugs, is a member of the UN Drugs Commission 2004-2007 
and one of the main contributors to the UN’s work against drugs.  
 
Organisation and coordination at central and local levels 
The main responsibility for coordinating drug policy, including preventive measures, care and 
treatment, lies with the Ministry of Social Affairs (formerly the Ministry of Health and Social 
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Affairs). The Ministry of Health has now been given a clearer responsibility for developing 
health services for drug users. 
 
Three central bodies work on drug prevention: 
 
· Norway Net, consisting of seven regional competence centres on drug and 
alcohol issues 
· The Directorate for Health and Social Affairs 
· The Norwegian Institute for Alcohol and Drug Research (SIRUS). 
 
They operate in the areas of education and competence development, quality and 
intervention development, grant administration and research and documentation. 
 
Pursuant to the adopted guidelines, the municipalities are responsible for preventive 
measures, as well as procuring places on treatment programmes for drug users. The basic 
principle is that the services must be anchored in the local community. Drug and alcohol 
policy is regarded as an important part of Norwegian welfare policy, and cooperation with 
other local services and sectors is vital. It is not only necessary to coordinate social services 
for drug users, but also their dealings with the mental health services, child welfare services 
and primary health care services. Moreover, close cooperation is also necessary with respect 
to housing assistance, the labour market and educational system. Voluntary organisations 
make an important contribution, including ownership and operation of treatment centres and 
residential facilities, often with public funding.  
 
The police work to prevent drug-related crime in two ways: firstly, by reducing the availability 
of drugs through police investigations and interventions and, secondly, by spreading 
information about the harmful effects of drug abuse. The police run an active information 
service aimed at different youth groups, parent groups and schools, in which the strategy is 
to prevent recruitment of new groups to the drug scene.  
 
Research commission 
On commission from the Minister of Social Affairs, a research commission has summarised 
existing knowledge on the effects of drug abuse prevention measures, identified a need for 
further research and pointed out political dilemmas and possibilities in this area in coming 
years. The commission submitted its report in February 2003. On the basis of this report, 
among other things, the Ministry of Social Affairs is now considering the future organisation 
of drug and alcohol-related research and the prioritisation of research topics. 
1.2 Legal framework 
Norway has no specific legislation that exclusively addresses drugs. Legislative responsibility 
is divided between the Ministry of Justice (the Penal Code), the Ministry of Social Affairs (the 
Social Services Act) and the Ministry of Health (the Act on Medicinal Products, the Act on 
municipal health services and the Act on specialist health services). The provisions of the 
Norwegian Penal Code were explained in the National Report for 2002. 
 
Legislative and regulatory changes 
Section 21 of Act no. 21 of 18 May 2001 on the execution of sentences opens for treatment 
as an alternative to imprisonment. In contrast to earlier practice, admission to treatment can 
take place at the time deemed most expedient for the convicted person’s rehabilitation, and 
not necessarily towards the end of the term in prison, which was the main rule under the now 
revoked Act no. 7 of 12 December 1958 on the execution of sentences, section 12. 
Decisions relating to the serving of sentences in an institution (cf. the Execution of Sentences 
Act section 12) are generally made by the Correctional Service at local level (cf. the 
Sentences Execution Act section 6). For persons sentenced to long prison terms (more than 
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10 years) or special sanctions, and high-security prisoners, the decision shall be taken at the 
regional level. The Correctional Service must not decide on alternative forms of serving 
sentences if security grounds dictate against doing so, or if there is reason to assume that 
the convicted person will evade completing the programme. 
 
The Act on execution of sentences also authorises the use of various forms of compulsory 
measures, among other things with a view to preventing the use of drugs during the serving 
of a sentence. Section 29, for example, authorises the use of urine samples, breathalyser 
tests or blood tests to detect such use. 
 
From 2002 ownership and operational responsibility for hospitals passed to the state. It is  
expected,  that also  the counties’ responsibility for institutions and associated specialist 
services for the treatment of drug users will be transferred to the state from 2004. 
In the autumn of 2002, the Ministry of Social Affairs introduced a bill proposing legislative 
amendments (“Drugs and Alcohol Reform 1” - Odelsting proposition no. 3 2002-2003). The 
proposed amendments were adopted by the Storting in January 2003. The Ministry of Social 
Affairs has furthermore introduced a bill (Odelsting proposition no. 54 2002-2003) containing 
proposals for the future organisation of interventions for which the counties will remain 
responsible under the Social Services Act (Drugs and Alcohol Reform 2). The bill is 
scheduled for consideration by the Storting in the autumn of 2003. The aim is to implement 
the reforms concurrently, with effect from 1 January 2004.  
 
Responsibility for the further development of low threshold health services and medically 
assisted rehabilitation was transferred to the new Ministry of Health with effect from 1 
January 2002. 
 
In March 2002 the Penal Code Commission submitted its final report on amendments to the 
Norwegian Penal Code, in which a majority of the Commission’s members proposed 
decriminalising the purchase, use and possession of small quantities of drugs for personal 
use, and reducing the maximum prison terms for drug offenders from 21 to 10 years. 
However, the Minister of Justice has rejected allowing any discussion of decriminalisation in 
the follow-up of the report, with reference to the Government's objective of opposing all forms 
of legalisation of narcotic substances.  
 
1.3 Laws implementation – Case law priorities and goals relating to drug users 
and drug-related crime 
Practice shows that the penalty for drug-related crimes is largely dependent on the 
substance and quantity involved. Involvement with cannabis is subject to more lenient 
sentencing than involvement with more dangerous substances. The nature of the 
involvement is also a very important issue with respect to sentencing. Greater leniency is 
shown in cases involving the importation or purchasing of drugs intended for personal 
consumption than in cases where the act was motivated by profit. 
 
In three recent court decisions (Norwegian Legal Gazette 1999, p. 33 and p. 1504 and the 
Supreme Court’s decision of 6 September 2000), the Supreme Court very clearly 
emphasises the need to clearly distinguish between the purchase and possession of drugs 
intended for personal use and the purchase and possession of drugs intended for sale. In the 
Supreme Court’s decision of September 2000, the first voting justice stated that this decision, 
in his opinion, "must be understood to entail a change of practice" compared to previous 
practice. It appears, therefore, that the Supreme Court wishes to make even more of a 
distinction than previously between involvement with drugs intended for personal use and 
involvement with drugs intended for resale. 
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1.4 Developments in public attitudes and debates 
One issue of current interest is the ongoing debate relating to the open drug user scene 
around Oslo’s central railway station and the recruitment of new young people to heavy drug 
abuse.  It has been claimed that one should draw on experience of models that have been 
tested with positive results in other European cities – such as Frankfurt. 
 
Critics point to what they argue is an imbalance between the severity of the crime and the 
guidelines pursuant to which different drug-related crimes are punished. The general level of 
punishment for crime in Norway is regarded as relatively low, while the level of punishment 
for drug-related crimes is tough. Individual citizens and lawyers have also raised doubts 
about how effective the current penal system is in preventing drug abuse, and asked whether 
the restrictive Norwegian control system perhaps creates more problems than it solves.  
1.5 Budget and funding arrangements 
In addition to the normal funding of operations, the Ministry of Social Affairs and the Ministry 
of Health have extraordinary budgetary funds at their disposal for the development of special 
high priority programmes in the areas of epidemiology, research, prevention and treatment. 
Such funds are channelled through SIRUS, the Directorate for Health and Social Affairs, the 
regional competence centres on drug and alcohol issues, specialised centres for substitution 
treatment and low-threshold measures. As funds are allocated to a large number of public 
bodies, institutions and organisations, either as operational funding or as allocations to 
projects, it is very difficult to present exact figures in relation to specific areas.  
 
In the research area (including alcohol, drugs and tobacco), SIRUS was allocated a total of 
EUR 3.43 million in operational funding in 2003. 
   
In 2002 the Ministry of Social Affairs allocated approx. EUR 21.6 million towards the 
development of social services and drug and alcohol measures i. Priority areas in 2002 
included the following:  
 
· Drug and alcohol prevention work at the local level 
· Competence building 
· Strengthening of the municipal social services’ work to help drug users 
· The work of voluntary organisations in the drugs area. 
                                                 
i  Government funds at the disposal of the Directorate of Health and Social Affairs are discussed 
in chapter 9 d) . Grants towards the reduction of drug-related harm are discussed in chapter 10.1 
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PART II  EPIDEMIOLOGICAL SITUATION 
Chapter 2. Prevalence, Patterns and Developments in Drug Use 
2.1 Main developments and emerging trends 
There was no demonstrable increase in the use of narcotic substances among young people 
between the ages of 15 and 20 from 2002 to 2003. SIRUS’ survey of 15-20 year-olds for 
2003 shows a marked increase in the use of alcohol, but no major changes from 2002 as 
regards the use of and attitudes to illicit drugs. On the contrary, the surveys from the last two 
years appear to indicate that the trend may be towards reduced consumption and more 
restrictive attitudes to narcotic substances among young people in this age group.  
 
No equivalent surveys have been made of the adult population in the last two years.  
But the fact that an increasing number of drivers are caught driving under the influence of 
narcotic and medicinal drugs is an indication of prevalence in the adult population. In 2002 
the number of cases increased by 20%. The samples taken reveal the presence of illicit 
drugs and a high proportion of medicinal drugs, particularly tranquillizers and sleeping pills. 
Figures from the Norwegian Institute of Public Health (NIPH), for instance, show a doubling 
in the incidence of Rohypnol.  
 
Various data sources and surveys show that drugs are being increasingly used and sold 
outside Oslo. There are hardly grounds for claiming that the number of young people at risk 
has increased, but the rural – urban constellation is in a process of change. Moreover, the 
socio-cultural dimension with increased availability of new substances in new milieus is a 
relatively clear trend viewed in a longer-term perspective.  
 
The estimated number of active intravenous users, most of whom inject heroin, indicates that 
the number is still increasing slightly from one year to the next. We still lack reliable 
estimates of other forms of problem use, such as persisting use of amphetamines, ecstasy 
and cocaine.  
 
The most marked change in relation to 2001 is the strong reduction in the number of drug 
fatalities in 2002. Figures from the National Criminal Investigation Service (NCIS) show that 
210 persons died as a consequence of narcotic substance abuse in 2002. This is almost 
40% fewer than in 2001, when 338 such deaths were reported. The reduction may have 
several causes, including reduced heroin availability, less pure heroin, the fact that an 
increasing number of opiate users are in substitution treatment and the considerable 
increase in low threshold health services.  
 
At the same time we have seen a clear increase in the number of seizures of several of the 
most common illegal substances in 2001 and 2002. NCIS’ seizure figures for 2002 show that 
the biggest absolute increases were for benzodiazepines and amphetamines. Seized 
quantities of benzodiazepines also increased markedly, particularly the quantities of 
Rohypnol. There was, on the other hand, a marked decrease in the number of heroin and 
ecstasy seizures, but in the case of ecstasy the quantities seized are large and have 
increased significantly. GHB, classified as a narcotic substance in 2000, still constitutes only 
a very small proportion of the total quantity seized.  
 
NCIS claims that there is much evidence to indicate a relationship between developments 
relating to ecstasy and heroin and the police and customs authorities’ investigations, and that 
there is reason to believe that the big seizures have limited the supply of these substances 
on the market, which in turn has led to fewer seizures among users. It is difficult to read 
changes in use directly from the seizure figures, but it will be interesting nevertheless, to 
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keep an eye on developments, especially in the use of heroin and on whether the 
considerable number of persons now in medically assisted rehabilitation, will result in a 
reduced demand for heroin. 
 
2.2 Drug use in the population 
2.2.1 General population 
The most recent national interview survey on the Norwegian population’s use of alcohol and 
other intoxicants was conducted in 1999. The main data from this survey were presented in 
the report for 2002. The next interview survey is scheduled to take place in 2004. The 
questions will be adapted to the EMCDDA’s standards, so that the data can be compared 
with that of other EU countries (standard table 01).  
 
Registration of the drug situation in some selected municipalities 
In 2002 SIRUS registered the drug situation in 60 selected municipalities by collecting 
information relating to the situation in 2001 from respondents in three public services in each 
municipality. Similar surveys have been conducted since 1992, but using different 
questionnaires so that the data are not comparable.  
 
The 60 municipalities constitute a relatively representative selection of the country’s 
municipalities in terms of both size and geographical distribution. All the counties were 
represented and the biggest municipality in each county was included. The selection was 
broken down into large municipalities (Oslo, Bergen, Trondheim, Stavanger and Bærum), 21 
medium-sized municipalities (with populations of between 20,000 and 99,000) and 34 small 
municipalities (with populations of between 1,000 and 19,000). 
The 60 selected municipalities included a total of 50% of Norway’s population at 1 January 
2002 (Statistics Norway: Population statistics). 
 
Data for the 2002 survey was collected from the police, health and social services and 
outreach services. They were all asked to estimate the number of drug users in their 
municipality, whether they had observed any increase in the availability of drugs and the 
priority given by the service in question to drug-related work during the year. The response 
was high (83-91.5%) for the three services involved.  
 
Since the survey concerned selected municipalities only, the data does not provide an overall 
picture of the situation for the country as a whole. Comparisons of the data are mostly on the 
basis of the three municipal size categories. Moreover, the data is largely based on 
information about persons known to the respondents. The data can therefore tell us 
something about tendencies and trends, but not about prevalence.  
 
In most of the selected municipalities both the police and social services had the impression 
that there had been a general increase in the number of users of narcotic substances from 
2000 to 2001. Very few respondents believed that there had been a decrease in number of 
users of any of these substances. Most respondents mentioned cannabis, amphetamines 
and tranquilizers as substances where the number of users had increased.  
 
Tranquilizers stood out as a “substance category” believed by many of the informants to 
have attracted more users. Rohypnol was mentioned most frequently.  
 
As regards amphetamines, more than half of the respondents reported that the number of 
users had increased in the last year. None of them thought that the number of amphetamine 
users had decreased or that this substance was not available in the municipality.  
In general, the police have the most "dramatic" assessment of changes in drug use. 
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In summary, the informants seem to think that young people under 18 mostly use cannabis 
and amphetamines. Most typical users of all narcotic substances are found in the 18-41 age 
group, while there are few in the over 41 age group who use amphetamines and ecstasy. 
 
One third of the social service informants and almost half of the police informants reported 
that opiates are also taken by smoking.  
 
More generally, the social services report that more drug abusers are injecting, regardless of 
the type of drug, and that they are experimenting with various combinations of drugs 
(www.sirus.no). 
 
In 2003 the collection of data will be extended to include all of Norway’s 434 municipalities, 
and the data will therefore give a more complete picture. The purpose of this annual 
reporting is primarily to provide information about how the situation is changing. Together 
with other methods, the registration will also enable us to provide more reliable estimates of 
problem drug use. 
 
2.2.2 Young people 
 
Annual youth survey 2003  
SIRUS conducts an annual questionnaire survey on the use of drugs among young people 
aged 15-20. The 2003 survey showed no major changes in the use of illegal substances. In 
recent years the difference between the proportion of young people at national level and the 
proportion of young people in Oslo who state that they have used various drugs has 
continued to decrease. While at the national level the proportion stating that they have used 
cannabis, ever and during the last six months, has been 15-17% and 8-10%, respectively, for 
the last three years, the corresponding figures for young people in Oslo are approx. 25-28% 
and 7-12% (figures 1 and 2).  
 
Figure 1. Percentage of young people aged 15-20 in Norway who report having used cannabis, ever 
and during the last six months, 1986-2003. 
Source: SIRUS 
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Figure 2. Percentage of young people aged 15-20 in Oslo who report that they have used cannabis, 
ever and during the last six months, 1968-2003 (three year sliding average). 
 
Source: SIRUS 
 
 
With respect to the percentage who report having used other substances, the trend has 
largely flattened out in the last few years (figures 3 and 4). For example, the proportion of 15-
20 year olds who report ever having tried ecstasy has remained at approximately 3% for the 
nation as a whole and 4-5% in Oslo. However, there appears to have been an increase in the 
percentage who report ever having used cocaine. 
 
 
Figure 3. Percentage of young people aged 15-20 in Norway who have ever tried different narcotic 
substances, 1986-2003. 
 
Source: SIRUS 
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Figure 4. Percentage of young people aged 15-20 in Oslo who have ever used different narcotic 
substances, 1970-2003 (three-year sliding average).  
 
 
Source: SIRUS 
 
 
As regards the availability of illicit drugs, the situation seems to have been relatively stable in 
recent years, measured by the responses to the question of whether or not young people 
have been offered various substances. At the national level, the proportion of 15-20 year olds 
stating that they have been offered cannabis has been around 40% for the last five years, 
while the proportion stating that they think they would be able to get hold of cannabis in a 
matter of 2-3 days should they want to do so, has been around 65%. Similarly at the national 
level the proportion stating that they have been offered amphetamines and ecstasy has been 
approximately 14-17% and 13-14% respectively.  
 
In Oslo the proportion of 15-20 year olds stating that they have been offered cannabis has 
been approx. 55%, the proportion stating that they would be able to get hold of cannabis in 
the course of 2-3 days has been approx. 70%, while the proportion stating that they have 
been offered amphetamines or ecstasy has been around 20-25% and 17-22%, respectively. 
 
The 2003 survey confirms the tendency in recent years that the proportion expressing that 
they have a positive attitude to narcotic substances is no longer increasing. In the last two or 
three years approx. 10% of 15-20 year olds at national level and 13% in Oslo have stated 
that they think cannabis should be sold freely in Norway. 
 
Statistical error margins 
The figures are subject to statistical error margins and must be interpreted with considerable 
care. Questionnaire surveys are always susceptible to certain sources of bias (not everyone 
responds, some responses contain deliberate or inadvertent errors, etc.) and the surveys 
referred to here targeted young people in general. There is reason to believe that young 
people who regularly use narcotic substances, whether it be cannabis or stronger 
substances, will be underrepresented in the surveys (www.sirus.no).  
 
The ESPAD survey 2003 (the Norwegian part) 
The European School Survey Project on Alcohol and other Drugs (ESPAD) is a European 
questionnaire survey on the use of drugs among 15-16 year olds. The survey is conducted in 
30 countries, including Norway. Three sets of data are now available – from 1995, 1999 and 
0
1
2
3
4
5
6
7
8
19
70
197
2
19
74
19
76
197
8
19
80
19
82
19
84
19
86
19
88
19
90
199
2
19
94
19
96
199
8
20
00
20
02
Amphetamines Heroin LSD Cocaine Ecstasy GHB
NATIONAL REPORT 2003   -  SIRUS 
 18
2003. The international report in which Norway will be compared with other European 
countries will be available in 2004.  
The Norwegian part of the survey includes just under 4,000 10th year students (9th year 
students in the 1995 survey).  
The main results relating to the use of drugs in the three surveys are shown in tables and 
figures. A more comprehensive report including updated results from the Norwegian 2003 
survey will be available in the autumn of 2003. 
 
Cannabis 
While there was quite a dramatic increase from 1995 to 1999 in the proportion stating that 
they had used cannabis, there was a clear decrease in 2003 in the proportion stating that 
they had used cannabis ever (figure 5), during the last 12 months (figure 6) and in the last 30 
days (figure 7), respectively. As illustrated by the figures, the decrease from 1999 to 2003 is 
quite marked. The same tendency can be observed in the annual youth surveys for the group 
aged 15-20.  
 
Figure 5. Percentage of boys and girls who state that they have ever used cannabis. 
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Figure 6. Percentage of boys and girls who have used cannabis during the last 12 months.  
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Figure 7. Percentage of boys and girls who state that they have used cannabis during the last 30 
days. 
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Source: SIRUS 
 
Other narcotic substances 
There was also a decrease for other narcotic substances from 1999 to 2003. The figures are 
small however and must be interpreted with care. One-two per cent state that they have ever 
used amphetamines, ecstasy, cocaine and heroin. The proportion stating that they had ever 
used medicinal drugs like Valium, Rohypnol and Mogadone without a doctor’s prescription 
was 2.7% in 1995, 3.5% in 1999 and 2.5% in 2003. 
 
Sniffing 
There was a gradual decrease from 1995 to 1999 which continued until 2003, except in the 
proportion stating that they had sniffed solvents during the last 30 days (www.sirus.no). 
2.2.3 Drug use in prison 
The prison population reflects in concentrated form the problems that exist outside the prison 
walls. The percentage of inmates serving sentences for violation of drug laws has been 
increasing in line with the increasing problems experienced in the rest of Norway. In 2001 
just under 30% of inmates in Norwegian prisons at any given time, had been convicted of 
various drug crimes. Additionally, some prisoners have been convicted of drug-related 
crimes that are directly related to drug use, but that are not reflected in the statistics. Typical 
examples of this are theft and robbery committed in order to finance drug use. 
 
The prison authorities estimate that around 40-60% of inmates in Norwegian prisons use 
drugs once or more during their term in prison. This estimate is based on previous studies 
carried out in prisons, including anonymised questionnaire surveys among inmates, and 
reports submitted to the Prison Board by prisons and from inspection rounds. 
 
After the new Act of 18 May 2001 on sentence execution entered into force, the prisons have 
improved access to control measures to combat drug use. Among other things, they have 
been authorised to take urine and blood samples on a general basis. Another new feature is 
that sniffer dogs can be used for searches of the person. Additionally, the right to search 
visitors has been introduced, and the right to hold these individuals until the police arrive. 
Moreover, health care personnel, on the request of the prison, can conduct body searches 
(cavity searches) of inmates in the case of suspected use or possession of drugs. There are 
also a number of other control measures, including the use of blue lighting in toilets, sniffer 
dogs and communication checks.  
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The number of body searches (cavity searches) has remained stable from 1993 to 2002. The 
total number of finds of drugs and user equipment increased from 1988 to 2002. In 1988 
there were 234 finds of drugs and 777 finds of user equipment, while in 2002 the number of 
finds was 651 for drugs and 1,008 for user equipment. The increase may be due to 
increased prevalence and use of drugs in prisons, but may also be related to improvements 
in the control procedures. 
 
The number of urine samples testing positive for drugs increased from 1,019 in 1988 to 
1,999 in 2002. But, given that the total number of samples taken increased from 6,706 to 
21,663 in the same period, the percentage testing positive dropped substantially from 15.2% 
to 9.2%. Some of the decrease can be explained by the fact that the statistics have become 
more precise since 2002, when legal narcotic substances (medicinal drugs and legally 
prescribed methadone/ subutex) and drugs taken before arrival in the prison were no longer 
included in the figures for illegal intake in proven samples. This means, in other words, that 
approx. 90% of the urine samples show no traces of illicit drug intake in prisons. The majority 
of the positive tests are for cannabis substances and various narcotic tablets. This 
corresponds with the seizures that are made (Ministry of Justice ) (Standard table 12).  
 
Cannabis is the clearly most frequently found substance in samples from inmates in prisons 
and open facilities (figure 8). Amphetamines and diazepam (active agent in e.g. Valium) are 
also frequently detected. This picture has not changed much in recent years, but an increase 
in flunitrazepam, the active agent in e.g. Rohypnol, has been registered (NIPH). 
 
Figure 8. Drugs detected in correctional service cases 
 
 
 
Source:   NIPH 
 
2.3 Problem drug use 
Estimates relating to the extent of problem drug use in Norway are based on the number of 
overdose fatalities. The estimates indicate the scope of intravenous abuse. In 1989 the 
number of injecting users at the national level was estimated at 4-5,000, in 1999 at 9-12,000, 
in 2001 at 10,500-14,000 and in 2002 at 11–15,000. This corresponds to a doubling from 
1990 to 1999 and probably a continued modest increase since then.  
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Heroin is the predominant injected drug. Amphetamines and cocaine may also be injected, 
but intravenous users of these drugs seldom die of an overdose. Hence, intravenous use of 
these substances will be underrepresented in the figures. Sustained or regular use of 
opiates, amphetamines or cocaine, when these substances are not injected, will not be 
included in the estimates of intravenous users. The actual extent of problem drug use is 
therefore greater than 11-15 000 persons. Approx. one third of the intravenous users are 
women, and this figure has remained stable over time.  
 
The problem user population seems to be getting older. Studies of persons visiting the 
needle bus in Oslo show that their average age has increased somewhat. This may be 
because few people are able to stop problem use and that the population of intravenous 
users is therefore growing older. The increase in average age may also be due to 
recruitment taking place from older age groups than previously.  
 
The growth indicated by the above estimated figures for intravenous drug use, does not 
necessarily mean that recruitment is continuing to increase. Even lower recruitment will 
contribute to an increase in numbers if few persons stop their problem use or die. The 
increase in the number being treated with methadone from 1999 to 2002 and stability in the 
numbers of places in other forms of treatment, indicate that the proportion who stop being 
active injecting drug users is higher than it used to be. This may be an indication that 
recruitment to intravenous drug use is not on the decrease.  
 
The municipal survey from 2002 and indicators of problem use around the country provide a 
basis for alternative methods of estimating problem use at the national level. Work on such 
supplementary figures relating to problem use has not yet been completed (standard table 
7). 
 
Risk behaviour 
Risk behaviour associated with injecting relates to the risk of infectious diseases, injuries 
sustained from incorrect injection and the risk of overdosing. In addition, surveys show that 
this group has poor general health and nutrition, particularly for heavy problem users. They 
are therefore very receptive to infections and disease in general.  
 
Experience of caring for drug and alcohol abusers and various low threshold responses show 
a large under-consumption of ordinary medical services among drug users. Low threshold 
responses include health services that do not require prior appointments and that target the 
problems of drug and alcohol abusers. Other services include accommodation and food, and 
other forms of care and activities. Needle distribution and free condoms are often an 
integrated part of these services. Such low threshold responses have been introduced in the 
big cities and some populous municipalities near cities (chapter 10). 
 
HIV testing continues to be extensive among intravenous users, with almost 90% having 
tested themselves in the last three years. The prevalence of HIV among intravenous users in 
Norway remains stable and low compared with most other European countries, even if the 
number of new cases registered in 2002 was the highest for many years (chapter 3.3). In a 
survey among users of the needle bus in Oslo (Hepatitis C survey by the Alcohol and Drug 
Addiction Service in Oslo), more than 70% stated that they were aware of their hepatitis C 
status, 58% stated that they had tested positive and 14% that they had tested negative. 
Blood tests showed the presence of hepatitis C antibodies in 80% of the same group. 
 
The extent of needle sharing has been measured using roughly comparable questions in 
surveys from 1992/2000 (User surveys of the needle bus) and 2002 (the Hepatitis C survey) 
among users of the needle bus. In 1992, 32% of all respondents stated that in the course of 
the last four weeks they had used a needle used by someone else (including their regular 
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partner) before them. The 2000 and 2002 surveys showed somewhat lower figures – around 
16%. This may indicate that there was a reduction in needle sharing over the ten-year period 
(SIRUS) (standard table 10).  
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Chapter 3. Health consequences 
 
3.1 Drug treatment demand 
Norway has established a registration system for the treatment of clients with drug and 
alcohol problems. The system is based on a client registration form, which is used to register 
the clients’ situations on requesting treatment, the client’s situation at the time treatment 
begins, and situation on the completion of treatment. The form is to be completed by the 
therapist based on an interview with the client, and should include variable sets that cover 
the ”core items” in the EMCDDA’s Treatment Demand Indicator. The system is designed to 
suit the needs of clients with both alcohol, prescription drug and illicit drug problems.  
 
Because of official regulations protecting the right to privacy, data from the client registration 
system is collected at the facility/ institution level before it is collated at regional and national 
levels as aggregate figures for each facility/ institution. The fact that national data is only 
available in the aggregate form means that it is not possible to distinguish clients whose 
problems are purely or primarily alcohol-related from clients whose problems are primarily 
drug-related. The form in which data are available also makes it impossible to check for 
duplicate data, i.e. treatment in which the same client appears for several treatment sessions 
in the same or different facility/ institutions in the same year. The client cannot be ”followed 
through the system” over time. 
 
Work is now in progress to develop an individualised registration system that can be used in 
conjunction with the EMCDDA’s Treatment Demand Indicator. Proposals have been drafted 
for an encryption system for data and personal identifiers for individual facility/ institutions, a 
system for secure data transfer from institutions to a central data administration, for choosing 
a central data administrator and storage system, and a provision concerning access to 
centrally stored data. These elements are, however, subject to approval by the Data 
Inspectorate. The Ministry of Health and the Ministry of Social Affairs are involved in this 
process. 
 
Table 1. Registered requests for and initiated treatment. Note: The same person may be registered 
more than once in the same year. Includes both individuals whose problems are primarily alcohol-
related and those whose problems are primarily drug-related. 
  
Year 
No of resp. 
institutions 
etc. 
No. of 
requests 
No. of initiated 
courses of 
treatment 
1998 110 18,115 13,541 
1999 110 20,426 15,700 
2000 113 26,462 18,981 
2001 106 23, 280 17,850 
 
Source:  The Bergen Clinics Foundation 
 
 
Table 1 shows the development of registered requests and initiated courses of treatment 
from 1998 to 2001. The records for 2002 are being collected. The fall in the number of 
institutions responding in 2001 was caused by reorganisation in Oslo and computer problems 
in several facilities/ institutions. Altogether, in the four years from 1998 to 2001, 145 different 
facilities/ institutions have supplied data to the client registration programme. Eighty facilities/ 
institutions have provided data in all four years.  
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When broken down by gender and age, the requests show a clear tendency towards a more 
even gender distribution the younger the clients. In 2001 women represented 43% and men 
57% of the requests in the 16-20 age group, while the figures were 21% for women and 79% 
for men in the 51-60 age group. Gender differences between different age groups followed 
the same trend in 1998, 1999 and 2000. 
 
Alcohol is the most frequently used intoxicant among most men, used by approx. 36%, while 
28% of the men use heroin/ other opiates most frequently. The most frequently used 
intoxicants among women are alcohol (28%) and heroin/other opiates (also 28%). Addictive 
prescription drugs are the most used drug among many more women (9%) than men (slightly 
over 3%). Ecstasy was the most frequently used drug in 14 cases in 1998, in 18 cases in 
1999 and in 82 cases in 2000. The figures for 2001 show that ecstasy is the most frequently 
used drug in 49 cases (figures 11 and 12 in chapter 15) 
 
Addictive medicinal drugs are the “second most used drug” by most clients, followed by 
cannabis. Alcohol and heroin/ other opiates are stated as being the “second most used drug” 
by approx. 4-5%, for both genders. In 153 cases ecstasy was the second most used drug, 
while in 27 cases it was LSD (the Bergen Clinics Foundation). 
3.2 Drug-related mortality 
There are two bodies in Norway that register drug fatalities: Statistics Norway (SSB) and 
NCIS. SSB’s figures are based on the medical examiner’s reports, autopsy reports and 
doctors’ declarations of death. SSB codes cause of death by using a Norwegian version of 
the international classification of diseases, accidents and injuries (ICD-10). The deaths 
included in these statistics are registered according to their determined underlying cause, i.e. 
drug use is the direct cause of death. NCIS’ registration system is based on reports received 
from police stations around the country.   
The figures from NCIS include cases of acute poisoning (overdoses) as well as deaths that 
are clearly related to the deceased persons abuse. Experience indicates that the actual 
number of drug-related deaths will be somewhat lower once autopsy reports become 
available from the Institute of Forensic Medicine. NCIS uses unadjusted figures for previous 
years, however, in order to have a correct basis for comparison.  
 
Table 2. Drug-related deaths. Total number of deaths and broken down by gender. Figures from NCIS 
and SSB (underlying cause of death).  
       
1991-2001 Number of deaths according to NCIS Number of deaths according to SSB 
       
 Men Women Total Men Women Total 
1991 74 22 96 66 22 88 
1992 78 19 97 81 23 104 
1993 77 18 95 76 17 93 
1994 102 22 124 105 19 124 
1995 108 24 132 114 29 143 
1996 159 26 185 173 31 204 
1997 149 28 177 160 34 194 
1998 226 44 270 228 54 282 
1999 181 39 220 191 65 256 
2000 264 63 327 302 72 374 
2001 286 52 338 327 78 405 
2002 166 44 210    
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*The figures from 1996 and onwards have been classified after a new revision. Hence the figures 
before and after 1996 are not directly comparable. Suicides in which narcotic substances were 
used are included as from 1996. 
Source:  NCIS and SSB  
 
NCIS’ records show that the number of drug-related deaths fell markedly in 2002.  The police 
districts report a total of 210 deaths - 166 men and 44 women – as a result of drug use in 
2002. This is 128 (almost 40%) fewer than in 2001 when 338 deaths were reported, and the 
lowest figure since 1997.   
The average age of the deceased in 2002 was 33 years for men and 34 years for women. All 
together 23 of a total of 27 police districts reported drug-related deaths in 2002. As in 
previous years, the Oslo Police District reported the highest number of deaths (79). More 
than one in three drug-related deaths took place in the capital, although Oslo’s share of the 
total has been decreasing in recent years (standard tables 05 and 06).  
Methadone-related deaths 
A comparison of the presence of methadone in forensic autopsies (i.e. test material analysed 
by NIPH) with the sale of methadone, shows a very strong correlation between the total 
quantity prescribed and the number of poisoning fatalities in which methadone was an 
important factor. A sharp rise has been seen in the number of such deaths over the last few 
years, paralleling the increase in the quantities prescribed. Poisoning by methadone alone 
accounts for 10% of the material on which figure 9 is based, while the rest being mainly 
combined poisonings. 
 
 
Figure 9  Methadone-related deaths in Norway 1991-2001 
 
 
Source:  NIPH 
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THC-related deaths 
In a study in 2001 of autopsy cases in which tetrahydrocannabinol (THC - the active agent in 
cannabis) was found to be present, six cases of sudden death without a clear cause of death 
were reported. By comparing identified THC concentrations, clinical data and autopsy 
findings the study found indications of acute heart failure in these persons. THC intake and 
its timing in relation to the symptoms, or in some cases death, have not previously been 
documented by measuring THC levels in the blood. Cannabis is generally considered a fairly 
non-toxic substance, involving little danger of serious poisoning or death.  
 
However, this study concluded that cannabis has a considerable acute effect on the 
cardiovascular system both in healthy individuals and those with heart conditions, and 
suggests that there may be a correlation between cannabis use and sudden heart failure. 
Such serious, but rare side effects can be detected after a substance has apparently been 
used safely over a long period of time (Bachs, L. and Mørland, H.).  
  
Causal factors 
The major changes in the total number of drug fatalities have no simple explanation. Factors 
that may have contributed to this development are: 
· The number of intravenous drug users has doubled over the last 10 years 
· A more prevalent injecting culture in Norway than in other countries, including the 
other Nordic countries. In Norway heroin is taken almost exclusively by injecting. 
· The heavy drug user group has grown older and is more debilitated both physically 
and mentally. 
· Except in 2002, heroin has been readily available and therefore dropped in price, 
which in turn has led some users to use larger doses. 
· Multiple use, whereby heroin is taken in combination with alcohol and/or prescription 
drugs such as Rohypnol, has become increasingly common. 
The substantial decrease in the number of drug fatalities in 2002 may be partly due to the 
sharp increase in the number of persons undergoing medically assisted treatment, both in 
Oslo and in the rest of the country. There has also been an increase in the number of low 
threshold services in the cities and big towns.  
Mortality among heavy drug users in Norway has been calculated in several follow-up 
studies. However, it is problematic to generalise from group-specific mortality rates to the 
entire population. Bretteville-Jensen and Ødegård (1999) emphasise the uncertainty 
attached to their estimate, which is based on a review of the available literature and 
stipulates an annual mortality rate of between 3 and 4% among intravenous drug users.   
 
The establishment of a Norwegian register of drug fatalities 
In order to follow the development in deaths due to overdoses and be able to evaluate the 
treatment programmes and preventive measures, it is absolutely necessary to establish a 
register of drug fatalities based on a uniform registration method. The Ministry of Health has 
therefore given the Norwegian Institute of Public Health the task of establishing a national 
register based on uniform registration. In order to stay in step with international 
developments, it is also important to ensure that statistics are comparable with the statistics 
of other countries. A reference group has been established, consisting of representatives 
from forensic medicine, NCIS, SIRUS, the Directorate of Health and Social Affairs and SSB.  
 
The project is in its first phase, which will consist of drawing up definitions of drug fatalities 
and criteria for subdivision into categories. Among other things, it is important to find criteria 
to distinguish overdose deaths from other causes of death, such as traffic accidents and 
suicides.  In addition to the conclusions from forensic autopsies and forensic toxicology 
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findings, reports from the individual police districts to NCIS will be important sources of 
information.  
The criteria for classifying drug fatalities adopted by the EMCDDA will be helpful in 
establishing the Norwegian register. In addition to harmonisation with other European 
countries, it is important that the new register covers specifically Norwegian conditions.  
 
So far the project has been allocated funding for 2003 and the register is expected to be in 
place in 2004. So far, it has not been decided which body will be responsible for maintaining 
and operating the register (NIPH).  
 
3.3 Drug-related infectious diseases 
HIV and AIDS 
In 2002, 205 cases of HIV infection were reported to the Reporting system for infectious 
diseases (MSIS). Only 16 of these cases concerned intravenous drug users. This represents 
a slight increase in newly diagnosed cases compared with recent years, but it is too early to 
say whether this represents an increase in the spread of disease among drug users. Half of 
these cases were reported from Oslo, eleven were men and five were women and the mean 
age was 36 years. Two of the cases concerned immigrants infected before arriving in 
Norway, both from Eastern Europe. At 31 December 2002, a total of 472 persons were 
registered as HIV positive with injecting use as the risk factor. This is 19% of all reported 
cases of HIV since 1984. 131 of the cases have been reported as having progressed to AIDS 
(table 3) (standard table 09).  
 
Table 3.  Proportion of intravenous drug users among persons infected by HIV or AIDS, showing risk 
behaviour in the form of injecting use, by year of diagnosis. 
 
 HIV 
Total 
HIV 
intravenous 
drug use  
Percentage of 
HIV intravenous 
drug use  
AIDS 
total 
AIDS 
Intravenous 
drug use  
Percentage of 
AIDS intravenous 
drug use  
1984-89 894 315 35% 144 8 6% 
1990 90 22 24% 59 13 22% 
1991 142 16 11% 59 16 27% 
1992 105 12 11% 50 8 16% 
1993 113 13 12% 64 13 20% 
1994 94 12 13% 74 19 26% 
1995 105 11 10% 67 8 12% 
1996 116 9 8% 56 12 21% 
1997 113 11 10% 34 8 24% 
1998 98 8 8% 39 5 15% 
1999 147 12 7% 29 7 24% 
2000 176 7 4% 38 6 16% 
2001 158 8 5% 27 5 18% 
2002 205 16 8% 33 3 9% 
total 2 555 472 18,5% 773 131 17% 
 
Source- NIPH 
 
Intravenous users were the group for whom fears of an uncontrolled spread of infection were 
greatest. The incidence of HIV in this group has, however, remained stable over the last 
decade with about 10-15 cases of HIV infection a year. The reason for this is not fully clear, 
but a high level of testing and degree of openness concerning HIV status in the user milieus, 
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combined with a strong fear of being infected and self-imposed discipline, are assumed to be 
important factors. Additionally, many of the sources of infection in the drug-using milieus 
have disappeared through deaths from overdosing or rehabilitation through substitution or 
other treatment. However, the extensive outbreaks of hepatitis A and B in recent years, and 
the high incidence of hepatitis C, show that needle sharing is still prevalent. The situation as 
regards HIV is therefore regarded as very unpredictable. 
 
When the virus was introduced to this group in the mid-eighties, around 250 drug users were 
probably infected in the course of a three-year period, which demonstrated how fast HIV can 
spread in user environments. The group’s high HIV test activity ensures good monitoring, 
however, and an increase in the spread of HIV in this group would probably be discovered 
quickly. 
  
Hepatitis 
Since 1995, we have observed an increase in the incidence of hepatitis A and B among drug 
users. This has coincided with a significant increase in the reported number of new 
intravenous users since 1995. During the nationwide outbreak of hepatitis A from 1995 to 
2000, 1,360 drug users with acute hepatitis A infection were identified. Only two cases were 
reported in 2002. The hepatitis B outbreak continued into 2002, when 120 of a total of 183 
cases of acute hepatitis B were among injecting drug users. In the period 1995-2002 the total 
number of reported cases of acute hepatitis B among injecting users was 1,417.  
 
The high incidence of hepatitis B among drug users has resulted in increased sexual 
transmission, often to younger women in the drug user milieus. The outbreaks have 
illustrated the fact that intravenous use is no longer limited to cities and large towns, but has 
spread to smaller municipalities all over the country. The outbreaks have led to free hepatitis 
A vaccine being offered to all drug users in Norway since 2000. Hepatitis B vaccine has been 
offered free to drug users since 1984. 
 
In Oslo small-scale prevalence surveys have been conducted in recent years, including one 
on hepatitis among drug users visiting the needle bus. In 2002 the survey showed that 60% 
of the 410 drug users examined had experienced a hepatitis A infection, 53% a hepatitis B-
infection and 79% a hepatitis C infection. In Norway hepatitis C is not monitored to the same 
extent as hepatitis A and B, and hence the number of newly infected victims of the hepatitis 
C virus among drug users is unknown. These Oslo surveys are the only regular prevalence 
surveys conducted among drug users in Norway. In connection with these annual prevalence 
surveys, drug users are also offered x-ray examinations to detect tuberculosis and 
vaccination against hepatitis A and B (NIPH).  
 
Other infections among drug users 
Syphilis, gonorrhoea and other sexually transmitted diseases are rarely reported among drug 
users in Norway. No outbreaks of tuberculosis have been registered among drug users in 
Norway. For several years, the City of Oslo has conducted regular x-ray examinations 
among drug users, and there are no signs that drug users in Norway are a risk group with 
respect to contracting tuberculosis. In the last five years, four sporadic cases of wound 
botulism have been diagnosed among drug users in Norway. The world’s first known case of 
systemic anthrax transferred through intravenous drug use was diagnosed in Oslo in the 
spring of 2000. This was an isolated case, and it is assumed that the heroin had been 
contaminated by anthrax bacteria in the country where it was produced. Skin infections and 
abscesses are not uncommon among drug users. In some cases they may become seriously 
septic/ toxic. Bacterial endocarditis is a well-known consequence of injecting. Every year a 
small number of cases of such infections among drug users is reported, but it is clear that 
many such infections are under-reported in reports to the Reporting system for infectious 
diseases (NIPH).   
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3.4 Other drug-related morbidity 
Co-morbidity is dealt with in chapter 16. 
3.4.1 Drugs and driving 
Statistics relating to driving under the influence of intoxicants have been monitored by the 
forensic toxicology and drugs and alcohol research division at NIPH (formerly the National 
Forensic Toxicology Institute - SRI) for many years. 
In the period 1990-2002 the number of cases in which the police suspected drivers of being 
under the influence of alcohol had stabilised at around 5,500 cases per year. The biggest 
change was in the number of cases in which the driver was suspected of being under the 
influence of intoxicants other than alcohol and medicinal drugs. I 2002 the number of such 
cases (5,161) was almost as high as for alcohol (5,486 ). The trend from 1990 to 2002 
shows:  
· A gradual increase in the number of cases over the last 11 years.  
· However, the increase from 2001 to 2002 is much greater than any previously 
recorded – almost 20%.  
· Benzodiazepines (tranquilizers and sleeping pills) are the most frequently found 
substances in these cases. Flunitrazepam, the active agent in Rohypnol, has 
increased dramatically (a doubling in the last year). In 2002, flunitrazepam was the 
most frequently detected substance. 
· There has also been a big increase in amphetamines – approx. 25%.  
· Methadone shows a strong increase, even if the absolute figures are much lower.  
· On average between two and three substances are found in each sample.  
· Intoxicants or medicinal drugs are found in almost 80% of the cases in which the 
police require drivers to take blood tests. 
· Norway is the leading country in Europe when it comes to catching drivers who are 
under the influence of intoxicants.  
 
The distribution between cases in which the offender was suspected of being under the 
influence of alcohol and cases in which the offender was suspected of being under the 
influence of other intoxicants is shown in figure 10. 
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Figure 10.  Number of traffic cases investigated by SRI/NIPH in 1990-2002, in which being under the 
influence of alcohol or other intoxicants was suspected. 
 
Source:   NIPH 
The detection of various narcotic substances is shown in table 4. 
Table  4. Detection of various narcotic substances in traffic cases investigated by SRI/NIPH in 1990-
2002 
  1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 
Cannabis 564 627 842 741 660 995 708 1 027 1 502 1 504 1 686 1 732 1 886 
Diazepam* 430 475 676 541 577 712 744 928 1 004 910 808 1 050 1 113 
Flunitrazepam** 233 255 212 221 198 270 321 458 540 603 656 1 252 2 107 
Amphetamines 233 216 391 475 533 937 898 1 081 1 327 1 290 1 312 1 587 1 972 
Morphine 72 108 107 142 193 261 311 392 483 533 601 539 452 
6-MAM***  6 29 64 92 172 195 263 317 320 307 295 213 
Ecstasy MDMA)     0 6 23 27 67 123 194 194 180 
Cocaine     10 9 6 19 40 80 118 135 166 
Methadone           22 64 102 
* Active agent in Valium, among others ** active agent in Rohypnol, among others *** chemical 
conversion product of heroin 
Source:  NIPH 
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Chapter 4. Social and Legal Correlates and Consequences 
 
4.1 Social problems 
Studies of Norwegian drug users show a major over-representation of various social 
problems. Many live under very poor housing conditions, in environments with high crime, 
violence and prostitution.  A study of users of the needle bus in Oslo, for example, shows 
that more than 4/5 received welfare or social security benefits, while only approximately 10% 
were in paid employment. Over half of the women had earnings from prostitution (Bretteville-
Jensen 2000).  
 
4.2 Drug offences and drug-related crime 
Legislation 
The Norwegian Penal Code section 162 and the Act on Medicinal Products section 31 (2), cf. 
section 24 (1), regulate drug offences. The Penal Code regulates serious offences, while the 
Act on Medicinal Products has provisions for what are considered less serious offences. In 
Norway, statistics are kept for crimes reported, investigated, prosecuted and for convictions 
relating to drug offences. However, information is not provided on the substances involved. 
 
Table 5. No. of reported and investigated drug offences.  
Penal Code, section 162 Act on Medicinal Products Total  
Reported 
crimes 
Investigated 
crimes 
Reported 
crimes 
Investigated 
crimes 
Reported 
crimes 
Investigated 
crimes 
1991 7 377 5 328 5 711 4 621 13 088 9 949 
1992 7 692 6 250 6 328 5 059 14 020 11 309 
1993 7 640 6 458 6 432 5 281 14 072 11 739 
1994 8 005 6 458 6 759 5 384 14 764 11 842 
1995 11 911 8 044 11 420 7 629 23 331 15 673 
1996 13 669 10 310 13 786 10 442 27 455 20 752 
1997 16 169 11 639 18 376 12 360 34 545 23 999 
1998 17 276 13 809 21 498 16 489 38 774 30 298 
1999 17 820 16 041 23 167 20 135 40 987 36 176 
2000 19 302 16 718 24 726 21 574 44 028 38 292 
2001 21 411 18 667 27 548 25 073 48 959 43 740 
2002 20 600  26 410  47 010  
 
Source: Crime statistics, SSB 
 
Crime statistics (table 5) reveal a clear rise in drug-related crime. During the period 1991 to 
2002 the number of violations of the Medicinal Products Act increased almost fivefold. The 
number of arrests for violations of section 162 of the Penal Code, which regulates more 
serious drug crimes, nearly tripled during the same period. Compared with other types of 
crime, the statistics covering drug-related crime clearly show the sharpest increase. The high 
number of cases can, however, be attributed to the fact that the same case may be 
registered as several violations if the person is reported or investigated for both use, 
possession and purchase for his/ her own use.  
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The number of persons charged for violation of drug laws has almost tripled from 1990 to 
2002 (table 6). Statistics on the number of reactions against drug offences show a similarly 
sharp increase (standard table 11). 
  
Table 6. Number of persons charged with drug crimes 
 Penal Code, s. 162 
Act on Medicinal 
Products 
Total 
1991 1 584 1 993 3 577 
1992 1 974 1 929 3 903 
1993 2 282 1 508 3 790 
1994 2 143 1 303 3 446 
1995 2 496 1 442 3 938 
1996 2 878 1 577 4 455 
1997 3 424 1 764 5 188 
1998 4 056 2 430 6 486 
1999 4 891 3 111 8 002 
2000 5 539 3 651 9 190 
2001 6 287 4 459 10 746 
 
Source: Crime statistics, Statistics Norway 
 
4.3 Social and economic costs of drug consumption 
a) In general it is always difficult to estimate the social costs of drug use. As regards the 
economic costs for municipalities, SIRUS carried out a study in 2003 on “Intoxication and 
psychiatry in the municipalities’ income systems”, commissioned by the Ministry of Local 
Government and Regional Development.  
 
Among the most important direct costs for municipalities are the municipalities’ own share of 
treatments costs and the cost of work directly among drug and alcohol users (outreach 
workers etc.). In total Norwegian municipalities spent approx. EUR 63 million on this work in 
2001 (net) ii. There are no corresponding figures relating to how much money the 
municipalities spent on mental healthcare, but there is reason to believe that municipal 
expenditure is moderate – both because the municipalities do not pay an own share for 
psychiatric treatment and because the funds allocated by central government for stepping up 
psychiatric healthcare cover many of the municipalities’ expenses. 
 
In addition to direct costs relating to drugs and alcohol and psychiatry, there are indirect 
costs, of which social security and child welfare expenditure stand out as particularly 
important. On the basis of user surveys we can assume that roughly 23% of social security 
expenditure is spent on persons with alcohol and drug problems.  Estimates based on these 
surveys show that the total municipal expenditure on drugs and alcohol abusers is at least 
EUR 275 million. This is a relatively small share of total municipal operating expenditure, but 
there are great variations between the different municipalities (SIRUS report no. 3, 2003).  
 
b) Central government expenditure on preventive measures and treatment of drug and 
alcohol abusers was described  in chapter 14 of the National Report for 2002. An overview of 
central government grants in 2003 is provided in  chapters 1.4 , 9 d) and 10.1.  
 
 
                                                 
ii Includes users of all types of intoxicants, both alcohol and narcotic substances. 
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Chapter 5. Drug Markets 
 
5.1 Availability and supply 
The seizures made by the police and customs authorities of different substances in recent 
years are a clear indication that use and abuse of the various narcotic substances 
increasingly takes place in all parts of the country. Seizures of cannabis, amphetamines/ 
metamphetamines and benzodiazepines have been made in all 27 police districts, cocaine in 
24 districts, heroin in 23 districts and ecstasy in 25 districts (NCIS’ six-monthly report 2003).  
 
Together with data from the survey of some selected municipalities (chapter 2.2 ), this is a 
reliable indication that drug use and drug dealing is increasingly spreading to small 
communities throughout the country, even if the problem is still most preponderant in the 
cities and large towns.  
 
Surveys are another means of measuring changes in availability. The annual survey of 
young people aged 15-20 shows, for example, that there has been an increase in the 
proportion of those stating that they have been offered cannabis from approximately 25% 
during the first half of the 1990s, to about 40% in recent years. Similarly, the proportion who 
state that they would be able to obtain cannabis within 2-3 days has increased from about 
55% to 65% during the same period.  
 
The increasing mortality rate confirms that the use of heroin is increasing throughout the 
country. Even though the number of drug-related deaths dropped sharply in 2002, such 
deaths were registered in 23 of the 27 police districts.  
 
The narcotics section at Oslo police district estimates that approximately 80% of all drugs 
that are smuggled into Norway are destined for Oslo and are spread to the rest of the country 
from there. The trend is that drugs are spreading to more and more police districts. Drugs are 
often smuggled through natural ports of entry such as the Swedish border crossings and 
ferry ports. New substances largely arrive in Oslo and the central eastern part of the country 
first. Once a market has been established for such drugs, they are then spread to other 
areas of Norway. 
 
5.2 Seizures 
NCIS registers drug seizures made by the police and customs authorities. In this way double 
registration is avoided in cases in which both the customs authority and the police are 
involved. The number of seizures is defined on the basis of the number of times a substance 
is detected and is quantified by different types of substances, the time of seizure and how it 
was carried out. In other words, multiple seizures are registered for one and the same case if 
different types of substances are confiscated. The same holds true if the seizures are made 
in different locations or at different points in time.  
 
Main trends in 2002 
The number of drug cases reported to NCIS in 2002 once again showed a marked increase. 
The number of drug seizures increased by approx. 10% compared with 2001, which was also 
a record year. The trend is not unambiguous however. Benzodiazepines - of which Rohypnol 
constitutes 3/4, and metamphetamines have increased most.  The increase is also great for 
medicinal pain killers classified as illicit narcotic drugs.  
It is also worth noting that the number of heroin seizures has dropped markedly, and we 
have to go all the way back to 1995 to find the same frequency of seizures. The amounts 
seized were, however, relatively large. 
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The number of cocaine seizures increased by 16%, and this can only be described as a 
marked increase, even though the rate of increase has decreased slightly compared with 
recent years.  
 
For ecstasy, the number of big seizures increased considerably, while the total number of 
seizures decreased by 14%.  
 
Cannabis remains the most frequently seized drug. In 2002 cannabis accounted for approx. 
1/3 of all seizures, but the increase is smaller than in the last 5 years. 
 
Seizures of GHB remain at a low level, on a par with what has been recorded during recent 
years. It seems that its prevalence is very marginal compared with other drugs. 
 
Based on the number of seizures, it appears that LSD has almost disappeared from the 
market. 
 
 
 
Trends in 2003 
NCIS’ figures for the first six months show a clear decrease in the number of drug cases and 
seizures. The decrease in the number of seizures (17% compared with the same period in 
2002) applies to most substances, except LSD and GHB, and is particularly marked for 
ecstasy, benzodiazepines, cocaine and heroin. 
On the other hand, there have been many big seizures of most types of drugs.  The 
quantities of cannabis, heroin, amphetamines, metamphetamines, khat, ecstasy, 
benzodiazepines and LSD are well above the average indicated in the six-monthly statistics 
in recent years. The number of seizures of GHB during the first six months has already 
exceeded the number of seizures made during the whole of 2002. 
NCIS assume that the reduction in the number of seizures is related to the fact that the police 
have given priority to investigating major drug cases and directed their efforts less at users 
and the final link in the chain of distribution.  
While the increase in seizures of flunitrazepam (Rohypnol) was quite dramatic in 2002, there 
has been a marked decrease in the first six months of 2003.  
This trend is confirmed by substance analyses in road traffic cases. In 2002, flunitrazepam 
was the most frequently detected substance. The trend in 2003 shows a decrease during the 
first six months. The decrease may be due to the fact that illegal importation from Eastern 
Europe has been considerably reduced. 
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The tables, figures and text included in the following relate to 2002 (standard table 13).   
 
  
Figure 11. Number of drug seizures 1995- 2002 
 
Source: NCIS 
 
Table 7. Number of seizures 2000 – 2002, broken down by the most common substances  
 Substance 2000 2001 2002 
Change in% from 
2001 
Cannabis 9 224 10 844 10 921 +0.7% 
Amphetamines 3 077 4 596 5 035 +9.6% 
Methamphetamines 173 392 695 +77.3% 
Heroin 2 314 2 501 1 906 -23.8% 
Benzodiazepines 4 265 6 024 8 056 +33.7% 
Pain killers 845 1 009 1 237 +22.6% 
Doping 469 643 697 +8.4% 
Cocaine 390 496 577 +16.3% 
Ecstasy 827 837 716 -14.5% 
Khat 255 198 238 +20.2% 
LSD 87 52 15 -71.5% 
GHB 83 82 75 -8.5% 
Opium 19 24 14 -41.7% 
Source: NCIS 
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Cannabis 
In 2002 seizures of cannabis totalled 1,221 kg. This is well above the average for the last ten 
years. Only three times previously has a greater quantity been seized in a single year. The 
number of seizures increase marginally compared with 2001. Hash accounts for more than 
85% of the total number of cannabis seizures.  
 
Most of the cannabis that reaches the Norwegian market is produced in North Africa. It is 
often transported via Spain, the Netherlands and Denmark to Norway. There are many 
players involved – both in the importation and at the receiving end, and the importation 
cannot be tied to any particular ethnic group. In most cases importation and reception is 
carried out by Norwegians.  
 
Amphetamines/ metamphetamines 
The quantities of amphetamines and metamphetamines seized in 2002 were 209 kg and 
23.6 kg, respectively, divided between 5,035 and 695 seizures. The quantities seized have 
almost trebled compared with the average for the last ten years, and the number of seizures 
has increased by 133% in five years.  
 
Ten years ago there were far more seizures of heroin than amphetamines. In 1998 the 
number of seizures was the same for both these substances, while in 2002 the frequency of 
seizures was three times higher for amphetamines and metamphetamines than for heroin.  
The average purity of seizures of more than 15 grams is estimated to be approx. 34%. This 
is significantly less pure than in 2001, when the average purity was 42%.  
 
Most of the amphetamines seized in Norway are produced in Europe and mainly originate in 
the Netherlands, Belgium, Poland and Estonia. Most of the metamphetamines that are 
seized are produced in the Baltic countries and imported by criminal groups of Baltic origin.  
 
Heroin 
A total of approx. 59.1 kg heroin was seized in 2002. Only in two previous years have the 
quantities seized been greater. There has been a marked drop in the number of seizures for 
the country as a whole, however, including Oslo. This trend was particularly marked in the 
last six months of the year. The number of seizures fell by 13% in Oslo, and by as much as 
24% at the national level. 
 
The average amount of heroin in the substance mix has been estimated at approx. 30% 
weight, which represents the lowest purity registered in any one year. It is worth noting that 
the purity was the same for large seizures as for the smallest seizures for the second year 
running. 
 
Ecstasy 
The number of “ecstasy” tablets seized in 2002 was 102,433. In addition, 75 g of powder 
containing ecstasy was seized. The quantity has never been this high before, and the 
increase on 2001 is marked. The number of seizures was only 716, however, and this is a 
decrease of approx. 14%.  There is reason to believe that this has to do with the fact that 
there were many large individual seizures. MDMA dominates the market and was detected in 
99.6% of the seizures. Only four seizures have been recorded for the substances MDA, PMA 
and MDEA.  
 
Neither 2C-B, DOB, 2C-J, 2C-T-2 or other known hallucinogenic substances were detected 
in the seizures made in 2002. 
 
New tablets are received nearly every week, and a total of 47 new logos were registered in 
2002, of which three turned out not to contain ecstasy. Compared with 2001, the supply of 
new tablets/ logos fell by about 25%.  
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”Ecstasy” tablets are produced illegally and are therefore not subject to quality control like 
commercial medicinal products. Nor is there any declaration of contents in connection with 
the distribution of the tablets. Despite this, very few deviations from the "norm" have been 
registered during the last 15 years; the great majority of tablets contain between 70 and 120 
mg of the active agent (MDMA). So far, opioids have not been detected in any of the tablet 
seizures. 
 
Benzodiazepines 
Throughout the country, the benzodiazepine group of substances has increased more than 
any other, both in terms of quantities and number of seizures. In 2002 the quantity seized 
was 1,251,100 tablets (an increase of 50% on 2001) in a total of 8,000 seizures (an increase 
of 33% on 2001). At present, benzodiazepines account for approx. one quarter of the total 
number of seizures in Norway. The number of seizures and the quantities seized have 
increased manifold in the course of just a few years. 
 
Rohypnol is the predominant substance, its share having risen from 60% to 76% in two 
years. Other frequently seized benzodiazepines are Valium, Rivotril and Sobril. 
Benzodiazepines are very often registered together with other substances (heroin, 
amphetamines, cannabis and ecstasy) in one and the same drug case. The great majority of 
cases concern drugs that have been smuggled into the country.  
 
Cocaine 
In 2002 a total of 35.8 kg cocaine was seized in a total of 577 seizures. This quantity was 
only exceeded in 1998 (due to one big seizure of drugs found in the sea) and 1999.  
In general, large quantities of cocaine are smuggled into Europe from South America, with 
Spain being regarded as the main route of entry. However, the number of seizures in Spain 
fell compared with the two preceding years.  
In the last two years the amount of cocaine in the powder seized has also been much lower 
on average than that registered in several decades. The purity of cocaine used to be more 
than 80%, while the average for 2002 is estimated at 51%. 
 
Other substances 
 
Khat 
The amount of khat seized decreased for the third year running. The number of seizures in 
2002 (238) was, however, much higher than in 2001 (198).  
 
LSD 
There was a marked decrease in both the quantity and number of seizures.  
 
GHB 
Seizures of GHB remain at a low level in line with what has been registered during recent 
years. 
 
Opium 
There was a marked decrease in both the quantity and number of seizures compared with 
recent years.  
 
Other opioids (medicinal pain killers classified as narcotic drugs) 
Both the quantity and number of seizures of substances in this medicinal product category 
increased markedly in 2002. A total of 70,000 medicinal doses were seized in a total of 1200 
seizures. One single seizure of Temgesic consisted of as much as 50,000 tablets. It is also 
worth noting that there was a relatively large increase in the number of seizures of drugs 
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containing methadone, which comprised 1,720 medicinal units divided between 65 seizures 
of methadone solution. In the course of three years the number of methadone seizures has 
trebled and the quantity seized has increased manifold. (NCIS) 
 
5.3 Prices  
 
The prices reported for different narcotic substances are based on information obtained from 
the narcotics section in the Oslo police district. The prices of the different narcotic 
substances vary according to the quantity being sold, so that the price per gram will be 
cheaper if one gram is bought than if individual doses are bought. Prices for small quantities 
of cannabis have remained stable over the last year, but the price for larger quantities (1 kg) 
has fallen significantly. The price of heroin remains stable following a marked price fall during 
the previous five-year period. There are minor changes as regards amphetamines, while 
ecstasy (MDMA) prices have been cut by almost half for large purchases (per 100 tablets). 
 
Table 8. Prices for some drugs in Oslo (January 2003). In Euros. Exchange rate: EUR 1= NOK 8.00   
 
 
Source: Oslo Police District 
The “price list” is based on information from users and dealers at different levels, as well as 
information received from police officers working in the narcotics section. Prices can vary 
widely at times, depending on quality, contacts and quantity.  
Price developments are also monitored in a study in Oslo on the price elasticity of narcotic 
substances. A price elasticity indicates how much the consumption of a product will vary as 
the result of an increase in the price of that product. Many people have claimed that those 
addicted to narcotics, particularly substances like heroin and amphetamines, will not be very 
sensitive to changes in price. It has been argued that addiction leads the addict to use 
approximately the same amount of the drug almost regardless of the price of the drug he or 
she uses. The results of the data gathered from intravenous drug users in Oslo indicate, 
however, that this is not correct. According to the study, both heroin and amphetamine users 
will adjust their consumption significantly if the price of the substance changes, and heroin 
abusers appear to be more price sensitive than amphetamine users (Bretteville-Jensen and 
Biørn 2002). The material also suggests that women are more price sensitive than men 
(Bretteville-Jensen 1999).  
 
Type of 
substance Dealer doses 1 gram 10 grams 1 kilo 
Heroin 0.1 g/19-25,  0.2 g/38-50   100-150  750-250  31,250-62,500  
Hash  12.5 (0.5-0.7 g) - 75-100 1,750-4,375 
Amphetamine 19-25 (0.2 g) 25-50 250-625 7,500-11,250 
Ecstasy 12.5-19 per tablet  6-7.5 per tablet (100) 3-4 per tablet (1000) 
Cocaine ca. 20 lines per gr.  ca. 31  750 – 1,250 37,500 – 75,000 
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Chapter 6. Trends per drug 
 
Cannabis 
There has been an increase in the use of cannabis in the course of the last decade. This is 
evident from, among other things, surveys and analyses of blood samples taken from drivers 
suspected of driving under the influence. The number of seizures has also increased, 
particularly in the last four years. The price of cannabis has remained relatively stable in the 
same period. The fact that cannabis has become more available on the Norwegian market is 
also illustrated by survey data in that an increasing proportion of the respondents state that 
they have been offered cannabis or would be able to get hold of cannabis should they want 
to use it.  
 
Synthetic substances 
Amphetamines are either injected or taken orally. Even though amphetamines have not been 
as predominant among intravenous drug users in Norway as, for instance, in our 
neighbouring country Sweden, amphetamines have been used extensively by established 
drug abusers, and particularly so outside the Oslo area. Together with ecstasy the use of 
amphetamines is part of the drug culture partly associated with the ”house” scene in the 
cities and large towns, and these substances are also a part of the party culture in some 
youth subcultures. Various data sources, such as seizures, surveys and drivers testing 
positive for ecstasy and amphetamines, indicate that the use of synthetic substances has 
increased and become more prevalent. 
 
Heroin/opiates 
Estimates indicate that the number of intravenous drug users has doubled during the last 
decade. Most of them inject heroin. Even though the number of drug fatalities decreased 
considerably in 2002, it remains high. More heroin is being seized throughout the country. 
The number of heroin seizures has dropped significantly since 2002, however. Even though 
it is difficult to read changes in use directly from the seizure figures for one single year, they 
seem to indicate a positive trend as regards the use of heroin. It must also be assumed that 
the now considerable number of people undergoing substitution treatment has somewhat 
reduced the demand for heroin.  
Cocaine/ crack 
The survey data do not indicate that cocaine is widely used. There has been an increase in 
the number of seizures, however, and even if cocaine seems to be infrequent among drug 
abusers, it is reported that cocaine, like ecstasy and amphetamines, has increasingly 
become part of the party culture in certain milieus. We do not know of any crack use in 
Norway. 
 
Multiple use 
Data from research on treatment and clinical reports indicate that most drug abusers are 
multiple users. Alcohol is usually part of the picture, either in combination or alternating with 
other substances. The extensive use of other narcotic substances in addition to heroin is one 
of the big problems in connection with medically assisted rehabilitation. 
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Chapter 7. Discussion 
 
7.1 Consistency between indicators 
There is consistency between the indicators, but some degree of uncertainty attached to the 
interpretation of the different indicators relating to the development of drug use in Norway. In 
the long-term perspective, there has been a consistent increase in the number of seizures, 
the number of drug offences, the proportion of the population that has tried different 
substances etc. Developments for ecstasy are a possible exception. In 2002 the number of 
seizures increased for all substances, with the exception of heroin and ecstasy. The 
quantities seized increased for these substances too, however. The price level, on the other 
hand, has remained relatively stable, which does not clearly point to an increase in 
availability. This is supported by the fact that the proportion of young people aged 15-20 who 
report having ever used narcotic substances has actually fallen in the last two or three years.  
 
7.2 Methodological limitations and data quality 
For Norway's part, several of the indicators provided by the EMCDDA are still inadequate. 
This applies in particular to data on clients undergoing treatment and estimates of heavy 
drug use. As far as drug-related fatalities are concerned, the data based on the ICD-10 
classification have been updated for previous years. Norwegian reporting on those arrested 
for drug offences, intravenous drug users with hepatitis, HIV and AIDS deviates from the 
guidelines provided. This is due to specific national procedures for reporting this type of 
information.  
 
The data on prevalence of drug use may also be somewhat unreliable. For example, a low 
response rate in the annual youth surveys means that they are not representative. The illegal 
nature of the different substances might also contribute to statistical underreporting. 
Moreover, young respondents might have fewer qualms about providing information about 
their drug use than older respondents, thereby contributing to a higher reporting rate for 
younger than older respondents. 
 
Estimates of the number of intravenous drug users have been made using a multiplication 
method based on registers of the number of drug fatalities. This method is based on there 
being a relationship between the number of drug fatalities and the number of users. One 
source of bias here could be that the figures for drug-related fatalities are not as reliable as 
they are assumed to be. Among other methods, the estimates are based on drug fatalities 
registered by NCIS. There may, however, sometimes be reason to question the grounds on 
which the police register a death as a drug fatality. Some cases might have been mistakenly 
defined as drug fatalities because the person was a drug user even though the individual 
died of other causes. SIRUS is in the process of developing several methods to provide 
better estimates of problematic heavy drug use.  
 
Drug offences are "victimless crimes" and are seldom reported by others. The number of 
crimes that are investigated and lead to convictions is therefore largely dependent upon the 
efforts of the police and customs authorities. Changes from one year to the next or variations 
between different districts are therefore entirely, or at least partly, attributable to differences 
in the intensity of control activity, without there necessarily being any difference in the 
number of crimes committed. 
 
Seizures of drugs, both the number and volume confiscated, vary according to the priorities 
and efforts of the police and customs authorities. Among other things, the seizure figures tell 
us very little about the actual volume of substances that reach the market and are illegally 
used. The figures for seizures can also be influenced by legislative changes.  
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PART III – DEMAND REDUCTION INTERVENTIONS  
Chapter 8. Strategies in Demand Reduction at National Level 
 
8.1 Major strategies and activities 
In Norway, little distinction is made between alcohol, medicinal drugs and narcotic drugs 
within the prevention and treatment field. This is reflected in the action plans and strategies 
over the last 15-20 years and in the implementation of preventive measures as well as 
treatment.  
 
The Government’s new Action plan to combat alcohol and drug problems (2003-2005) 
outlines three strategically important goals for a policy on drugs and alcohol:  
 
1. Prevention of all forms of alcohol and drug abuse, with particular focus on preventive 
work among children and young people 
2. Improved availability of efficient advisory services, help and treatment for persons 
with drug problems and their families 
3. Significant reduction in the incidence of drug-related damage to health and the 
number of drug-related fatalities. 
 
The Government aims at establishing a low threshold for receiving help, and a high threshold 
for discontinuing such help. The main objective is to considerably reduce the harmful health 
and social effects of drug abuse. The action plan points out that in the field of alcohol and 
drug prevention, parents, local neighbourhoods, voluntary organisations, municipal, county 
and state agencies must constitute a chain of measures that compliment one another. There 
must be particular emphasis on measures that address the greatest needs and most dire 
situations, and areas where measures have been documented to have the best effect. 
 
The Government points out that the interventions used must knowledge-based and constitute 
cost-effective ways of attaining the goals. It will be important to ensure that all interventions 
carried out by the public sector, or with public funding and approval, comply with specific 
quality criteria. This requires, among other things, that the interventions are evaluated and 
that the evaluation is such that both the short and long-term effects of the interventions are 
made clear. The evaluation should be based on clear, universal criteria, including a shared 
understanding of what constitutes good prevention and successful treatment.  
 
The Government will establish a system for follow-up whereby new and existing measures 
are structured on the basis of the new goal and instrument structure. There will be 
requirements for clearly defined targets, target groups and measurement criteria, and for a 
planned evaluation to be implemented concurrently with the intervention itself.  
 
Two expert advisory committees were appointed in 2003 – one on alcohol and one on drugs. 
They focus on a user perspective because the Government considers it important that also 
families/ other care personnel and former drug users participate in the committees with their 
first-hand knowledge and experience. The committees are to provide the Government with 
ongoing advice about specific drug policy challenges, evaluate interventions, propose new 
ones and stimulate the development of more knowledge. 
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8.2 Approaches and new developments 
8.2. a) New, innovative approaches 
The Government’s action plan outlines a pilot project to ”develop targeted and coordinated 
preventive efforts at the municipal level”. The project has three cornerstones: procurement of 
the relevant local data; broad, coordinated development and implementation of intervention 
measures; and evaluation. The project is innovative in that it is inter-sectorial. The work will 
cut across the boundaries between the different administrative and organisational levels, and 
public and voluntary efforts will be combined.  The pilot project will be evaluated by SIRUS. 
8.2. b) Socio-cultural developments relevant to the reduction of demand 
The traditional view of how a drug career starts is that smoking hashish gradually evolves 
into experiments with other, harder drugs, of which amphetamines/ecstasy are currently the 
most likely. Qualitative data give some indication that this picture may be about to change. 
New drug career patterns may emerge, in which ecstasy or amphetamines are the door 
openers to illicit drug use, even if this tendency is not as yet confirmed by quantitative 
studies.  
 
In several youth subcultures, there appears to be a tendency for drugs which have long been 
linked to a specific youth subculture to now also be adopted by other groups, and thereby 
become detached to some extent from their original cultural context.   
 
It is a reasonable assumption that all these spectacular trans-national youth cultures are 
innovative at the outset (often inspired by movements in other countries), only to end up as a 
part of the big popular culture landscape to which the majority of young people belong 
(mainstream position). How this takes place and what happens to the drugs associated with 
these cultures is less certain. We do know that ecstasy, for example, like cannabis, does not 
seem to disappear along with the youth culture which introduced it (Mushuus G; Rossow I; 
Vestel V. 2002). 
8.2. c) Public opinion 
Public opinion on drugs can be said to be largely stable. Very generally speaking it can be 
said that the vast majority of the population condemn, and do not use, narcotic substances. 
The same majority has a correspondingly positive attitude to, and uses, alcohol. 
 
The mass media play a pivotal role in maintaining this picture. The media’s presentation of 
alcohol and narcotic substances is completely different in many respects: The choice of 
focus, degree of problematisation and use of value-loaded words etc. help to create a picture 
of narcotic substances as a major and grave problem, while alcohol is most often presented 
outside of a corresponding problematic context (Norwegian official reports – NOU 2003:4).  
8.2. d) New research 
In September 2001 the “Research commission on the knowledge base for drug and alcohol 
policy” was appointed by the former Ministry of Health and Social Affairs, its terms of 
reference being to provide knowledge that would serve to enhance the scientific basis for 
decision-making in the area of drugs and alcohol. The commission submitted its report to the 
Ministry of Social Affairs in February 2003. 
 
The commission employed two strategies for collecting relevant knowledge on topics relating 
to the prevention and treatment of drug and alcohol problems.  
 
1. Searching the literature for systematic outline articles of a certain quality published in the 
English language, and a Swedish and a Scottish summary dealing with the relevant topics.  
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2. In order to obtain more detailed material concerning national data, all the relevant 
Norwegian milieus were contacted, so that the commission could gain access to reports/ 
publications from the period since 1980 that contained evaluations of  measures. (Norwegian 
official reports - NOU 2003:4).  
 
Its conclusions are discussed in chapter 9.1 d) Evaluation studies and results. 
8.2. e) Specific events 
No specific events to report. 
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Chapter 9. Prevention 
9. a) National Strategy 
The government’s action plan (2003-2005) divides preventive measures into two types of 
complimentary measures: 
 1. Supply reduction, where efforts are aimed at influencing the production, distribution and 
sale of different drugs, and where prohibition, regulation and control will be the most 
important means employed. 
 2. Demand reduction, aimed at influencing the purchase and use of drugs. The means of 
achieving this will consist of different forms of educational and attitude-building measures 
and other preventive measures, as well as control measures such as taxes and regulation 
and control of use.  
 
Central elements of preventive work in Norway are based on: 
· Viewing prevention and health-promotion as two inter-related aspects   
· Directing preventive measures at individuals and specific risk groups, as well as large 
population groups  
· Taking a long-term view of prevention 
· The municipalities have a central role in preventive work 
· Broad mobilisation of various voluntary organisations. 
9. b) Organisation and coordination of preventive efforts in Norway 
The Ministry of Social Affairs has overall responsibility for drug issues, including preventive 
measures.  
 
The Directorate of Health and Social Affairs has been assigned responsibility for coordinating 
the implementation of preventive strategies and interventions.  
The drugs and alcohol competence centres have been given the task of assisting in the 
implementation of drugs and alcohol policy by the Directorate of Health and Social Affairs. 
Each competence centre has one or more speciality areas in which it is expert and about 
which it has a national responsibility for disseminating knowledge iii. The competence centres 
have an important role in cooperating with the municipalities in their regions to develop 
competence, methods and interventions in the prevention field. 
                                                 
iii The competence centres have the following speciality areas: 
REGION NORD (NORTHERN NORWAY): Counties: Nordland, Troms and Finnmark  
· Nordland's Clinic – www.nordlandsklinikken.no Speciality area: Group therapy approach to drugs and 
alcohol problems 
REGION MIDT-NORGE  (CENTRAL NORWAY) Counties: Nord- og Sør-Trøndelag, Møre og Romsdal  
· Central Norway competence centre for alcohol and drugs  – www.mnk-rus.no Speciality area: Youth and 
drug use, young drug addicts  
REGION VEST (WESTERN NORWAY) Counties: Sogn og fjordane, Hordaland and Rogaland  
· Rogaland A-centre  - www.rogaland-asenter.no Speciality areas: Families and children of school age, 
alcohol and drugs in the workplace  
·  The Bergen Clinics Foundation – www.bergenclinics.hl.no Speciality area: Women and drugs and 
addiction, female drug addicts 
REGION ØST (EASTERN NORWAY) Counties: Oppland, Hedemark, Akershus and Østfold  
· Sanderud Hospital, Drug addiction ward – www.sanderud-sykehus.no Specialty area: Double diagnoses 
– psychiatry and drugs, gambling addiction 
REGION OSLO.  
· Alcohol and drug addiction service – City of Oslo -  www.rusmiddeletaten.oslo.kommune.no Specialty 
areas: New trends of use among young people 
REGION SØR (SOUTHERN NORWAY) Counties: Aust-Agder and Vest-Agder, Telemark, Buskerud and Vestfold  
· Borgestad Clinic – www.borgestadklinikken.no Specialty areas: Pregnant addicts and addicts with small 
children. 
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Prevention of drug and alcohol abuse is otherwise a municipal responsibility as set out in the 
Act on social services. Municipal social services shall work to prevent and combat the use of 
alcohol and other drugs through information and outreach services and spread information 
on the harmful effects of such use. Drug prevention work shall mainly focus on local 
measures, emphasising the interplay between home, school, the social and health sectors 
and the leisure and cultural sectors. The goal is to achieve coordinated and inter-disciplinary 
efforts.  
How the work is organised is up to the individual municipality. In most municipalities 
responsibility lies with the social services, but some of the bigger municipalities have elected 
to establish dedicated positions for the coordination of crime and drug prevention efforts. The 
aim is to strengthen preventive work by making it easier to coordinate the efforts of the 
different services and sectors. 
Building on the idea that coordination of efforts can be cost effective, and that youth milieus 
and drug milieus cut across municipal boundaries, inter-municipal cooperation on drugs has 
been initiated in some areas.  
In addition to the public sector, voluntary organisations engaged in the drugs and alcohol 
field play an important role in preventive work. These organisations have their own rules and 
guidelines for the activities that they run.  The Directorate of Health and Social Affairs has a 
grant scheme, under which voluntary organisations can apply for funding for their projects. 
9. c) Overview of central government funding for preventive work 
(Exchange rate used: 1 Euro=8 NOK) 
 
In 2003 the Directorate of Health and Social Affairs allocated a total of EUR 7,454,000 to the 
seven competence centres on drug-related issues. The allocations are meant to cover 
expenses relating to day-to-day operation and the development of interventions. 
 
The Directorate of Health and Social Affairs administers four grant schemes for preventive 
work, from which funding can be applied for according to specific guidelines. Grant schemes 
and available funds for distribution in 2003: 
 
1. ”Grants for alcohol-free establishments providing overnight accommodation etc.” : 
EUR 469,500 
2. ”Grants to the Norwegian centre for the development of drug-free milieus” : EUR 
685,000 
3. ”Grants to voluntary organisations engaged in the drugs and alcohol field” EUR 
4,356,625 
4. ”Other grants” (deserving national/ regional measures aimed at the prevention of 
drugs and alcohol abuse) EUR 937,500.  
 
In addition EUR 725,000 was allocated to prevention work through the Norwegian Tripartite 
Committee for the Prevention of Alcohol and Drug Problems in the Workplace (AKAN). 
 
9.1 School programmes 
9.1 a) Central guidelines/ specific action plans 
Schools have long played a central role in preventive work. Education on alcohol and drugs 
is incorporated in the national curriculum plan, under which it should be integrated with other 
lessons (National Curriculum Plan of 1997). The goal is to carry out active preventive work in 
elementary and secondary schools in order to combat the use and abuse of alcohol and 
drugs. This is underlined in the government’s action plan (2003-05). The government wants 
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”knowledge-based drugs and alcohol education in schools that focuses on the students’ 
social skills and ability to master situations and with active parent participation” as one of 
several measures to prevent drug use. 
 
There are currently a great number of so-called drug prevention programmes and measures 
aimed at schools, but the quality of such measures is very variable. This year, therefore, the 
Directorate of Health and Social Affairs initiated the development of a joint strategy for the 
coordination of drugs and alcohol prevention efforts in schools, with clear recommendations 
with respect to what, on the basis of scientific criteria, can be regarded as expedient and 
effective programmes. A committee has been appointed to prepare the recommendation 
scheme. The committee consists of representatives of the Directorate of Health and Social 
Affairs and the competence centres. The work is expected to be completed in 2004. 
9.1. b) Models/ principles for school programmes 
The committee preparing the recommendation scheme will emphasise programmes and 
interventions that have a documented effect and/or are based on research-based principles. 
Central elements will include efforts over time, ensuring support from those in charge of 
schools, all-inclusive and coordinated efforts by those involved, cooperation between home 
and school, parent involvement, programmes which include or are designed to carry out 
process and results evaluations.  
9.1. c) Examples of school programmes/ interventions in schools  
Most of the school programmes currently in use focus on primary prevention. Some focus 
mainly on tobacco and alcohol, others on social skills and mastering rather than on actual 
drug and alcohol use. Only a few target youth at risk and/or have drug prevention as their 
main focus. The programme concepts can provisionally be broken down as follows: 
 
w Dialogue/ communication programmes in which issues and situations are described in 
a way that enables the participants to reflect and communicate with others about 
these topics (”Youth and drugs and alcohol”, ”Time breakers”, ”This year’s first-time 
users”, ”the Rainbow programme” etc.)  
w Peer education; Peers (in this case youths) teach/ pass on knowledge to each other 
(”Dialogue conferences”, ”Future” etc.)   
w Education programme/ guidance programmes (”Freezing point”, ”Local guide” etc.) 
w Lifeskill training programme (“Lions Quest”, “Step by step”). (standard table 19: 
School programmes) 
9.1. d) Evaluation studies and results 
The Research Commission’s report on research in the area of drugs and alcohol, included an 
evaluation of school programmes targeting children and adolescents. The commission 
divided the measures into two main types: didactic and interactive. In this context, “didactic 
measures” means different forms of classroom teaching in which the main emphasis is on 
adult “experts” conveying factual information to the students. The aim is to develop negative 
attitudes to drugs and alcohol, prevent damage and postpone use. These programmes focus 
on the idea that sufficient knowledge will result in correct behaviour. By “interactive 
measures” they mean educational schemes with participant involvement and in which the 
focus is on strengthening the students’ ability to make good choices in difficult situations 
(mastering).  
 
The evaluation of drug-related measures is based on seven outline articles. Two of the 
articles are of reasonably high quality, the remainder are of medium or poor quality. The 
results must therefore be interpreted with some care. The number of primary studies is 
slightly less than 400, 90% of which are from the USA. The results of this summary of 
knowledge relating to drug-related measures show: 
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· that it is well-documented that school programmes increase the students’ level of 
knowledge about drugs and the dangers of using them, while attitudes and behaviour 
are affected to a lesser extent; 
· that it is well-documented that interactive programmes are more effective than 
didactic teaching methods; 
· that only short-term effects have been demonstrated, measured in terms of 
differences between intervention and control groups, while good studies of high 
quality and with a long follow-up period are lacking; 
· that the DARE (drug abuse resistance education) programme, whereby the police are 
brought in to teach in the schools, is probably not expedient. 
 
Only two of the Norwegian studies have result indicators that included drugs (attitudes and 
use). They underpin the results of the international studies, particularly as regards the finding 
that interactive schemes can result in positive changes in behaviour in the short-term. But 
these studies have a short follow-up time, and it has not been documented that any of the 
interventions that were evaluated have an effect in the long term. There has been little 
investigation of undesirable side effects. 
 
The Research Commission concluded, therefore, that the primary effect of the programmes 
is on the actual level of knowledge, while behaviour is less affected. Interactive programmes 
are more effective than didactic programmes, but these measures appears to have little 
effect in preventing drug use among those groups that are at risk with respect to abuse (NOU 
2003:4). 
 
In 2001 the former Directorate for the Prevention of Alcohol and Drug Problems (now the 
Directorate of Health and Social Affairs), ordered an external evaluation of the four grant 
schemes for preventive measures relating to drugs and alcohol. A report was submitted in 
2002 (NOR Consulting AS). The evaluation started with an evaluation of objectives, 
regulations and awarding practice, and went on to examine some individual projects to 
assess the products and effects that the funding had resulted in. The main conclusion of the 
report was clear: The grant scheme as it had been practised until then could not be said to 
promote the intention of stimulating efforts to prevent drug and alcohol problems. The report 
made clear recommendations for changing practice. In 2003, as a result of this evaluation, 
the Directorate of Health and Social Affairs started work on changing the grant schemes. 
9.1. e) Research projects 
No new information is available concerning research into specific drug and alcohol abuse 
prevention programmes/ interventions in schools in the current year. One expert group 
appointed by the Ministry of Education and Research and the Ministry of Children and Family 
Affairs produced a report in 2001: "Evaluation of programmes and measures to reduce 
problem behaviour and develop social skills". Fifty-six different programmes were evaluated 
but only 9 programmes were recommended for use in schools. None of these was 
specifically related to drugs. Only one programme – Dan Olweus's programme to combat 
bullying – was recommended without reservation. Eight other programmes were evaluated 
as promising, but they all required further evaluation and, in part, further development, before 
it could be ascertained whether they actually had the desired effect. The report can be read 
at http://skolenettet.ls.no/sosial-kompetanse. 
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9.2 Youth programmes outside schools 
9.2. a) Definitions 
The criteria for being designated a youth intervention/ youth programme outside schools is 
that the activity is not directed at students during school hours. Hence, measures linked to 
schools – such as various programmes for parent involvement, though organised through 
schools, where the meetings are held in school in the afternoons/ evenings, will belong in this 
group.  
9.2. b) Types and descriptions of youth interventions outside schools  
At the end of the 1960s a system of public outreach services was established in a number of 
municipalities, and today there are 63 such services, covering most of the cities and large 
towns. They are engaged in outreach work among children and young people. On average 
each unit has two-three employees. The outreach service in Oslo is the biggest with 25 
employees, all with professional qualifications. Their activities encompass different 
preventive measures directed at older children and youths, including contact with young 
people and helping those who have developed drug and alcohol abuse problems to get 
treatment. The project, "Stop the dope not the dancing" was initiated in Oslo in 1995 as a 
collaboration between the outreach service in Oslo and young enthusiasts from the house 
scene on an information campaign on drugs in the house and party scenes. The project has 
changed its name to "Future" and is now found in four cities/ towns: Bergen, Trondheim, 
Tønsberg and Oslo, as part of the activities of the outreach services.  
 
”Future” targets young people aged 13-22 who are interested in/ belong to the rave/ techno/ 
trance subcultures. The objective is: to create good norm transmitters in drug-free 
subcultures, prevent/ reduce the damaging effects of drugs, create alternatives that can 
compete with drugs and focus on new trends and developments in this subculture.  The 
cornerstone principle of the project is ”youth-to-youth” contact. Young people (called dozers) 
work voluntarily in the projects in the different towns (standard table 21).  
 
Much of the municipal prevention work is based on various interventions/ programmes based 
around schools: various parent and local community-based activities. Examples are: 
 
· ”Time breakers” is a programme targeting adults with responsibility for children aged 
6-12. It is a communication programme intended to provide parents/ guardians with 
issues and descriptions of situations that can be discussed, reflected on and raised 
with others. 
· ”Parent cooperation on drug and alcohol prevention” is an intervention programme 
targeting parents of 8th year students (lower secondary school). Parent meetings are 
organised around various topics, the aim being to strengthen the bonds between 
parents and boost their authority to set limits for their children’s experimentation with 
drugs and alcohol. 
· ”This year’s first-time users” is based on a parents’ meeting of parents of 8th year 
students and includes the use of a handbook to get parents to reflect on their own 
views on the topic. It is a dialogue-based programme, intended to get parents to talk 
to each other by dividing them into groups. The focus is on communication – on using 
one’s own resources in cooperation with others (standard table 19: School 
programmes). 
 
A number of voluntary organisations engaged in the drugs and alcohol field run their own 
programmes and interventions/ measures aimed at young people outside schools with 
funding from the Directorate for Health and Social Affairs. 
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9.2. c) Statistics and evaluation results 
Føre Var (“Earlier warning system”) is a project, which was started in Bergen and Oslo in 2002 , 
to further develop methods of collecting information on new trends and modes of use of narcotic 
substances among young people. The objective is to identify new and upcoming drug trends, 
provide in-depth information in order to inform practitioners and politicians, increase the 
accuracy of political interventions and increase the effectiveness and use of management by 
objectives in the practical field, update survey questionnaires and increase cooperation between 
different agencies.  
A report on the “Earlier warning system” in Bergen was published in June 2003, based on a 
comparison of information from autumn 2002 and spring 2003. It showed little change in 
availability and use for the majority of the illicit drugs. It showed a flattening out and possible 
reduction in the availability of Rohypnol during the period in question. There has been an 
increase in the use of anabolic steroids in connection with body building.  
9.2. d) Further education and training for professionals in the prevention field 
 
Further education 
There are 12 different training programmes within the drugs and alcohol field in Norway. All 
are university college based, and most offer 20 credits (60 points). They aim to provide a 
general introduction to the drugs and alcohol field by covering the whole range of issues from 
early prevention to treatment and after-care.  
 
Training in outreach work 
The Alcohol and Drug Addiction Service’s competence centre in Oslo (RKS) is working to 
integrate outreach work/ field work/ visiting services with the Service’s other professional 
training with a view to developing national expertise in this area. 
The work is based on the joint efforts of RKS, the National Association of Outreach Workers 
and the City of Oslo’s outreach service and aims to:  
· Establish a two-semester course of training in outreach work in cooperation with a 
local university college. The aim is a 30-credit course.  
· Intensify the work on a new textbook manuscript in this field.  
· Market an English “introductory book” on field work, such as (drug) prevention work 
among young people. To be carried out in cooperation with the European Council’s 
Pompidou group  
· Initiate structured evaluation projects by different outreach services to make the work 
being done more visible and identify success factors. 
9.3 Family and childhood 
9.3. a) Definitions 
There is no shared, uniform and unequivocal definition of drug and alcohol prevention 
measures aimed at families and children. But the government’s action plan emphasises that 
the situation of children is a particularly important priority area, and the government wants to 
increase resources to make it possible to intervene as early as possible.  
9.3. b) Types/ descriptions of interventions aimed at families and children 
We know a lot about the consequences for children of living in families where there is 
substance abuse. Studies have shown that the incidence of a number of problems is higher 
among the children of substance abusers, and there are proven correlations between 
substance abuse in the home and criminality during adolescence and adulthood (West & 
Pinz 1987, Miller & Jang 1977, Christensen 1994). When these children grow up, they are 
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also reported to suffer from psychosomatic problems, depression, eating disorders and 
borderline problems (Black et. al. 1986, Kashubeck 1994, Belliveau et. al. 1995). 
 
The public duty to intervene on behalf of children living in families where there is substance 
abuse and/or other forms of serious neglect is also regulated by law. Each municipality has a 
child welfare service which, after an evaluation of what is best for the child (the Child Welfare 
Services Act section 1), can if necessary remove the child from the family by force. The child 
welfare service also has a preventive role, and shall provide help, support and guidance to 
families (long) before it becomes necessary to take over daily care and control. 
 
All municipalities have health clinics for children. They employ doctors and nurses and 
sometimes also midwives. They carry out pregnancy checks and all newly-borns are invited 
to participate in a vaccination programme stretching over two years, followed by a health 
check at the age of five. Many health clinics follow a practice of visiting the home soon after 
children are born. The health clinics thus act as public bodies that reach most families with 
small children, and their personnel can have an important role to play in the area of 
substance-abuse prevention. 
 
On this basis the Borgestad clinic competence centre, whose special competence is 
"Pregnant addicts and families with children”, has initiated a training programme aimed at 
health clinic employees. The programme focuses on drugs and alcohol work in health clinics, 
with special emphasis on increasing the employees’ ability to take action. This training 
programme will be continued next year. 
 
Different voluntary organisations have also become involved in the issue of drugs and 
alcohol use during pregnancy and parents' attitudes to drugs. Among others, the Blue Cross 
has developed a programme called "Children in the danger zone", which aims to educate the 
network surrounding children to recognise, understand and act when children suffer as a 
result of adult neglect. The programme provides various services for local health clinics, 
kindergartens, primary and lower secondary schools as well as inter-sectorial co-operation. 
The message is directed at adults, but is about children.  
 
Parents Against Drug Abuse is an organisation for drug users’ close family members. The 
objective is to offer the families of drug users help to help themselves and to help the 
problem user back into society. The organisation has around 60 local branches. They 
organise courses, seminars and meetings and engage in individual support work. 
9.3. c) Research projects and evaluation results 
There are no recent results from major research projects in Norway in this area. 
 
  
9.4 Other programmes 
9.4. a) Regional and local strategies relevant to the regulation of the leisure sector.  
Many municipalities have drugs and alcohol policy action plans. These provide guidelines for 
local drug-related work, in the areas of prevention, treatment and rehabilitation, and also 
outline local drugs and alcohol policy strategies/ instruments relating to licences for serving 
alcohol, opening hours for the sale and serving of alcohol etc. 
9.4. b) Brief analysis of the framework for leisure-based activities 
There are many players who run leisure-based facilities, even though there are no statutory 
requirements in this area. A number of municipal facilities exist, such as after-school clubs or 
activity houses/ multi-use halls. The drug prevention effect of such facilities is at best indirect 
in that people who might otherwise be adrift are ”caught” and offered meaningful activities.  
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Voluntary organisations are most active in this area, however. They include various 
ideological (religious, humanitarian, political) associations/ organisations, various youth 
organisations, sports clubs etc. Each organisation has its own objectives and rules. Some, 
such as ”Youth against drugs” and the ”Association against drugs” have specific focus on 
drug prevention, but the vast majority do not. Insofar as what they provide can be said to 
have a preventive intention (or effect), they also qualify for inclusion in the category health-
promoting activities. 
9.4. c) Central framework for regulating licensed premises etc. 
The most important regulatory mechanism relating to licensed premises is the ”Act on the 
sale of alcoholic beverages etc. The Alcohol Act provides a framework that regulates the sale 
and serving of alcohol, while the licensing authorities are the municipal councils. In cases of 
breach or non-fulfilment of requirements imposed on the licensee, their licence can be 
withdrawn. Note: A licence can also be withdrawn in the case of repeated drug dealing on 
the licensed premises.  
9.4.d) Applicable guidelines for the leisure sector and how they are enforced. 
There are no formal guidelines or regulations. 
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Chapter 10. Reduction of drug-related harm 
10.1 New initiatives in 2003 
In 2003 efforts to expand low threshold health services for heavy problem users have been 
intensified. The central government allocates EUR 5,250,000 for such health measures in the 
municipalities. This is an increase of EUR 1,750,000 compared with 2002. This year 27 
municipalities will receive funding for various measures, compared with 24 municipalities last 
year. Several of the municipalities that have previously received support, now have the 
opportunity to extend and strengthen the services offered.  
 
Low threshold health services target heavy problem users who are incapable of availing 
themselves of the normal health services. Services include offering problem drug users 
health checks, vaccinations, user equipment, protection against infectious diseases, 
guidance and follow-up after overdoses. It has been demonstrated that such measures reach 
the most abject problem users. They are also an important contribution in fighting overdose 
fatalities. In several municipalities low threshold measures are integrated with other health 
services, such as the accident and emergency service and ambulance service. New 
measures, including dental health measures and "street psychiatry support measures", are 
being tried out.  
 
In Oslo an action plan has been drawn up to provide alternatives to the drug milieus in the 
city centre. The action plan was launched at the end of 2002 as a result of the work of a 
working group consisting of representatives of the Ministry of Justice, the Ministry of Health, 
the Ministry of Social Affairs, the Ministry of Children and Family Affairs, the Ministry of Local 
Government and Regional Development, Oslo Police District and the Oslo’s Municipal 
Department for Welfare and Social Services. The working group proposed measures 
intended to break up the drug abusing milieus in the centre of Oslo in order to prevent the 
extensive drug dealing and reduce recruitment.  
 
These measures are aimed at achieving a more active rehabilitation of, and care for, the 
clients, so that they as far as possible can be offered meaningful welfare services where they 
live and can stay during the day. These measures also aim to provide alternative social 
milieus, so that the number of drug abusers in the centre of Oslo will be reduced. Further 
interventions by the police and municipal services will target new recruits to these milieus.  
 
The Ministry of Social Affairs has given the City of Oslo a grant of EUR 625,000 for three 
projects under the action plan. The three projects are:  
 
· return to/ resettlement in the home municipality 
· an extension of the residential training programme and follow-up 
· referral from low threshold measures.  
 
These funds are additional to the previously mentioned grant schemes available to 
municipalities. Moreover, in the budget for 2003 the Storting allocated EUR 500,000 to Oslo 
Police District, earmarked for following up the action plan. These funds are mainly being 
used to increase the manning of the police unit at Oslo Central Station, in addition to 
following up the cooperation with the City of Oslo and the Emergency Child Protection 
Service. 
 
The implementation of the action plan will be evaluated by SIRUS.  
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10.2  Description of interventions 
Needle distribution programmes 
Since 1988 Oslo has had a bus doing the rounds of the streets, providing clean needles and 
condoms free of charge. The bus now distributes 2 million needles annually. Other large 
municipalities also distribute needles, often using a combination of self-service dispensers, 
outreach services and one or more low threshold points of contact, often in co-operation with 
the health services. This service is first and foremost a disease prevention effort and has 
hopefully contributed to the low incidence of HIV among drug users in Norway. The incidence 
of hepatitis continues to be high, however (see chapter 3.3.). In 2003 the needle distribution 
programme in Oslo was moved into permanent premises alongside a low threshold health 
service (standard table 10). 
Low threshold health measures 
Those who are heavily addicted to drugs often have extensive health problems of both a 
mental and somatic nature, but the ordinary health services have not managed to deal with 
these problems. This is true of primary health-service physicians as well as hospitals. In 
1999, so-called field nursing stations were established in Oslo, in connection with low 
threshold day shelters and institutions at six locations in the city. These offer street level 
healthcare to out-patients. The intention is to provide healthcare and healthcare information, 
register health problems and any needs for medical assistance, provide rudimentary 
treatment for somatic problems and channel users into the established health and social 
services. The programme is non-bureaucratic and free of charge to the users. Those who 
wish to visit a field nursing station do so anonymously without an appointment, regardless of 
whether they are under the influence of drugs or not. The field nursing stations in Oslo now 
have about 2,000 clients. Similar programmes of varying scope have also emerged other 
places in Norway, for example the Strax house in Bergen and the Social Medicine Centre in 
Tromsø. 
 
Over the last four years the field nursing stations in Oslo, in association with the needle bus, 
have run vaccination campaigns against hepatitis, and also completed a successful x-ray 
programme.  
 
A separate nutrition project has also been carried out at a rehabilitation centre in Oslo for 
women with drug problems. It turned out that many of the women suffered from malnutrition 
or undernourishment. Greater emphasis on regular meals has proven to have a positive 
effect on their health. 
 
Oslo has prepared an injection room, linked to the field nursing stations in the city centre. A 
political decision on whether or not to put this room to use is pending (see chapter 1.1.) 
Outreach work 
Many of Norway's municipalities have a long tradition of outreach work targeting drug users. 
The objective is partly to offer assistance and guidance to new recruits to the drug scene at 
an early stage, and to help people get out of the drug milieus quickly. (See chapter 9.2. on 
outreach work). 
Outreach services have also been established, more geared to addressing emergency 
situations, making referrals and following up those at risk of overdosing. These services also 
carry out home visits and drive people home or to a detoxification station. For example, in 
Oslo the Outreach and Coordination Service (OKT) has access to mobile funds that can be 
used to help clients in need of treatment or care to get assistance quickly, also in those 
cases where the municipality has no spare capacity, but where there are openings 
elsewhere. In most cases the OKT cooperates closely with the ambulance service when 
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someone has overdosed, and it operates its own follow-up service for clients who have 
survived an overdose. 
 
The PRO Centre in Oslo is a competence centre that addresses the needs of street 
prostitutes, both through outreach work and by providing a warm-up shelter. Other 
municipalities also run similar services. One of the six field nursing stations in Oslo is at the 
PRO Centre and it offers low threshold health services to prostitutes. Similar measures are 
also found in other towns and cities. 
 
The Alcohol and Drug Addiction Service in Oslo cooperates with the ambulance service to 
offer courses in first aid, not only to active drug users in downtown Oslo, but also to the 
police, shop workers, railway station security staff and persons manning the public toilets, 
café and restaurant personnel and others who work daily or move in areas frequented by 
drug users. It is not known how effective this is, but the number of overdose fatalities in the 
city centre has dropped significantly in recent years. 
10.3  Standards and evaluation 
Most harm reduction programmes in Norway have been carried out without extensive 
scientific evaluation. As harm reduction programmes in Norway have become more goal-
oriented, greater emphasis has also been put on proper evaluation, although few long-term 
results are available as yet. However, trial projects with methadone have been evaluated 
both in terms of the process and client status. The field nursing stations in Oslo were 
evaluated after six months. The needle bus was evaluated in 1997, and it has also formed 
the basis for several studies of the drug using community.  
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Chapter 11. Treatment 
The Ministry of Social Affairs has the chief responsibility for co-ordinating care and treatment. 
A closer examination of how this is organised is provided in chapter 1.1. 
 
Treatment is by and large voluntary, but pursuant to the Act on social services (section 6-2) 
drug users can be held in an institution for up to three months on the decision of the County 
Social Welfare Board. Individuals who are voluntary admitted can enter into an agreement to 
be held for up to three weeks (section 6-3). The intention behind the use of compulsion is to 
motivate the client for further treatment.  
 
Pursuant to the Act on social services (section 6-2 litera a), pregnant drug abusers can be 
admitted to an institution and held there for the duration of their pregnancy, if their abuse is 
such that the child, in all probability, would sustain congenital damage and voluntary 
measures are deemed insufficient.  
 
Section 6-2 litera a) is used actively by the social services when voluntary approaches are 
not possible. This authority can also be used 'passively' in the sense that it has a 'disciplinary' 
effect on pregnant drug users who are negative to all forms of intervention by the health 
services, but who will nevertheless agree to voluntary measures when they learn about the 
social services' access to compulsory detainment. 
 
11.1 Drug-free treatment and healthcare 
Drug-free treatment aimed at achieving a future drug-free existence is still the main approach 
adopted in the majority of Norwegian treatment programmes.  
 
A wide array of treatment and care programmes has been developed in Norway based on 
different professional and ideological approaches. Treatment alternatives vary from 
professional psychotherapeutic approaches to simpler approaches in which acceptance of 
the Christian message plays a central role. Psychiatric assistance to out-patients is offered 
by psychiatric clinics for children and adolescents, open social medicine clinics, and 
psychiatric youth teams. Psychiatric outpatient clinics for children and adolescents offer 
treatment to children and adolescents under the age of 18 for all types of mental disorders 
and problems. There are approximately 70 psychiatric outpatient clinics for children and 
adolescents and approximately 100 psychiatric outpatient clinics for adults across the 
country. Some adult clinics employ personnel dedicated to working with drug and alcohol 
abusers suffering from mental disorders. The psychiatric youth teams work especially with 
adolescents and young adults between 15 and 30 years of age who have both drug 
problems and mental health problems. Norway has 34 psychiatric youth teams. Instead of 
separate youth teams, four counties have employed dedicated alcohol and drug personnel in 
the psychiatric clinics for adults.  
 
Institutions offering 24-hour services include everything from small institutions with few 
employees and few clients to large institutions with several departments. Ownership varies: 
They may be owned by the county, by public or private foundations, limited companies or be 
privately owned. Approximately two-thirds of the 24-hour facilities available to alcohol and 
drug abusers are in private hands. Hence organisations like the Church’s City Mission, the 
Pentecostal Church’s Evangelical Centre, the Blue Cross and the Salvation Army, among 
others, represent a considerable supplement to public institutional services. 
 
Common to all these treatment alternatives is that they are generally open to problem users 
of alcohol, medicines and drugs alike and are mainly financed by public funds.  
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Emergency and detoxification institutions offer detoxification and motivation for admission to 
other rehabilitation programmes. Emergency institutions may be units forming a part of 
treatment institutions or other facilities that focus on saving lives in a crisis. 
 
In addition to the facilities described above, there are a number of care programmes for 
abject abusers who have little potential for rehabilitation, offering them supervision and care 
in a drug-free environment. Other such facilities include halfway houses, which aim to 
improve the residents' ability to master a “normal life”. 
  
11.2 Research on treatment and evaluation 
SIRUS is charged with the task of conducting and disseminating research and 
documentation on drugs and alcohol issues, with particular emphasis on social-scientific 
issues. The institute's research can be divided into five main areas: the drugs and alcohol 
market, drugs and alcohol use and drugs and alcohol culture, preventive measures, 
consequences, treatment and care.  
 
SIRUS is responsible for the treatment study, "What benefit, for whom and at what cost? A 
prospective multi-centre study of the treatment of drug abusers". Co-operating partners in the 
study include 20 treatment programmes in Oslo and surrounding municipalities. The project 
is intended to evaluate treatment approaches and different treatments for drug users to 
ascertain whether any of the responses lead to better results than the rest for the various 
groups of drug users. The project is organised as a prospective multi-centre study in which 
482 clients from 4 different treatment categories were followed up over two years. The clients 
were interviewed using a structured survey (ASI) to measure drug use and psychosocial 
status and they also completed three questionnaires (MCMI, SCL-25, CTQ) themselves. 
Moreover, information is being collected relating to what the clients think of their own drug 
abuse, and their evaluation of the treatment they have received and the follow-up by the first 
line services. The clients are also asked to describe different “life events” after leaving the 
recruitment programme. Information about resource consumption and accounts will be 
obtained from the programmes, and questions asked about treatment ideology and structure. 
The number of hours spent on the different treatment programmes for each client will also be 
registered. Information will also be collected from different databases, such as the Criminal 
Records Register, the National Insurance Administration, the Cause of Death Registry and 
Statistics Norway (various social security payments, welfare support measures).  
 
The second and final follow-up of the 482 clients was concluded in July 2002. A very good 
response rate was achieved in both follow-ups; 92% in the first follow-up and 88% in the 
second. 2.9% of the sample (n=482) died before the first follow up, and 1.5% died before the 
second follow-up (n=468), i.e. in the course of a two-year observation period. The average 
age of the clients admitted for treatment was 31 years, and the proportion of women was 
33%.  
 
So far, the project has made several interesting findings. When it comes to the benefit of the 
treatment, the study shows that the average intake of drugs such as heroin and 
amphetamines was halved following treatment. There were also clear improvements in other 
areas: the number of days including criminal activity fell by 60%, and the number of days 
mental problems were experienced was reduced by 20%. However, these average figures 
conceal large variations between the different types of measures, in terms of both the extent 
of the change and the costs of the treatment.  The Psychiatric Youth Teams (PUT) were by 
far the cheapest treatment, in which an average of EUR 3,750 was spent per client. 
However, this treatment was also the least effective in reducing the intake of heroin (7% 
reduction). On the other hand, the PUTs achieved the best mental health improvements 
(40% improvement measured by the number of days with mental problems). 
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The treatment that on average produced the best results in terms of reduced use of heroin 
was medically assisted rehabilitation (MAR) (reduction of 69%). But unlike the PUT clients, 
MAR clients reported a considerable increase in the number of days with mental problems 
(85%). The average spending on each MAR client was EUR 28,875 (slightly more than EUR 
37.5 per client day).  
 
The improvement in terms of heroin intake in clients who have undergone traditional 
medication-free treatment in residential facilities is almost as great as in MAR clients, and the 
results are better in terms of mental health. The cost of treatment in such facilities is higher, 
however, averaging around EUR 81,250 per client (approx. EUR 250 per treatment day).  
 
As expected, the most costly treatment in residential facilities was that for very young clients 
(average age 16 years) attending so-called youth facilities. Average expenditure here was 
EUR 187,000 per client. The period of treatment was also the longest, which explains the 
high costs. These clients had almost no intake of heroin before admission, but there was a 
big reduction in their use of cannabis. These clients had the biggest percentage reduction in 
days with criminal activity (88%). All in all, the figures show that no type of treatment scores 
”best” on all counts. MAR was, for instance, best in terms of reducing the use of heroin, while 
the PUTs were best in terms of reducing mental problems (SIRUS ).  
 
11.3 Substitution and maintenance programmes 
Medically assisted rehabilitation using methadone and other medication for heavy drug 
abusers has been available nationally since 1998. National guidelines have been adopted, 
describing responsibilities and the organisation of medically assisted rehabilitation at regional 
and national level. The system is based on specialised regional centres, although the 
municipal health and social services are responsible for follow-up.  
At present the system has been extended so that this type of assistance is offered in all 
municipalities and counties. 
 
 
Objectives 
The objective is to provide assistance and treatment for heroin abuse and social and health 
problems. Everyone who satisfies the criteria is to be offered assistance in their home 
municipality. The scheme aims to provide clients with adequate housing, an orderly life and 
orderly finances. It should offer clients a sense of belonging and leisure pursuits outside the 
drug milieus. The use of medicinal drugs for intoxication purposes and the use of illicit drugs 
must stop.  
 
Criteria 
The criteria for admission were revised in 2000 and made less restrictive: The applicants 
must be at least 25 years old, heavily addicted to an opiate despite reasonably extensive 
treatment and have several years of opiate addiction behind them. The criteria may be 
deviated from on the basis of an overall evaluation of health and social problems. When 
methadone or another adequate medicinal drug is necessary for treating serious illnesses, 
the criteria relating to age and previous treatment do not apply.  
 
Availability and organisation 
Clients apply for treatment themselves through their social services centre, possibly in 
cooperation with their doctors or therapists in other programmes. The application must 
include a description of their drug use and previous treatment. An action plan shall be 
prepared describing the existing problems and the cooperation planned to remedy them. It is 
also possible to apply for and start treatment while in prison. The treatment can be initiated 
without application in a psychiatric or mental institution after an evaluation by the responsible 
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head doctor, but cannot be continued after discharge without an application being made. 
Doctors can also use opiate medicines for crisis intervention and for clarification of 
assistance needs and an intervention plan. 
 
The application shall be sent to and approved by the regional centre. The treatment starts 
under the auspices of or in the regional centre with weaning from other drugs, the necessary 
examinations and stepping up of medication.  Medication is prescribed by the centre or by 
doctors cooperating with the centre. 
 
Unless there are special requirements, the treatment will mainly be ambulant, the medication 
being supplied by chemists or in a regional facility.  Admission may take place for weaning 
purposes, crisis intervention or treatment of specific conditions. 
 
Medication and administration methods 
Methadone and buprenorhin are currently approved for this type of treatment. Methadone 
must be drunk as a solution, normally in dosages from 80 to 130 mg/day. Buprenorphin is 
taken in the form of high-dose resoriblets (Subutex) for putting under the tongue, normally in 
dosages of 8-16 mg/day. Considerably higher dosages are used when required. 
 
In both cases the medication  must be taken daily under supervision until the patient is 
deemed to be stable and to have sufficient mastery of his/her drug problem. Permission for 
take-home use can then be granted to an increasing degree. Medication can be collected for 
maximum one week at the time. The right to home-use is conditional on documented drug 
checks in the form of supervised urine samples.  
 
Suboxone containing buprenorphin and the antagonist naloxon are available on a 
registration-exemption basis, but are so far not extensively used. It is expected that this drug 
will lead to less need for control, since it cannot be taken intravenously. This reduces the 
danger of overdosing and the tendency to resell will be less of a problem. 
  
Psychosocial assistance interventions 
Such interventions are conditional on individual action plans being drawn up which describe 
targeted measures for dealing with the problems present. Every client must have a social 
consultant who maintains regular contact and acts as coordinator. Inter-disciplinary 
responsibility groups must be established for all patients with multiple problems, the social 
consultant and the regular GP sharing principal responsibility with the specialised centre. All 
clients’ rehabilitation needs will be evaluated and they will be offered education and training 
on this basis. Consultations with a psychologist will be provided if required 
 
In practice, there may not be sufficient local competence or interest for this work. The 
specialised facilities also have varying capacity in relation to the demand, which has 
generally been very high. There have been some complaints that the treatment programme 
has to a large extent consisted of handing out medication, control measures and 
conversations about the use of drugs. 
 
Leakage 
The system aims at a high degree of control, and the main rule is therefore daily 
administration of medication under supervision. Close follow-up including regular supervised 
urine samples is a condition for being given medication. Generally this works well when the 
regional facilities are in charge of follow up and, if applicable, handing out medication. 
Nevertheless, methadone and Subutex have been registered on the illegal market and in 
samples taken in connection with suspicious driving and overdoses in persons who are not 
registered for treatment. Some of these finds can possibly be attributed to illegal importation, 
but a substantial proportion must come from MAR medication. The impression is that the 
problem is increased by decentralisation, with reduced regional control by specialists. 
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Evaluation and statistics 
All clients are registered as patients in a regional facility, even if their medication is 
prescribed by their GP. The centres submit four-monthly reports to the national centre in 
Oslo on the number on waiting lists, the number of admissions and the number of 
discharges. Figures are therefore available three times a year. There has been a steep rise 
in the number of clients. The latest figures from  August 2003 show an aggregate figure of 
2,285 for the country as a whole ( table 9 ). 2,995 persons have undergone treatment at 
some stage or another. The most recent records show that 585 persons were waiting for 
treatment or for their applications to be considered.  
Table 9. Number of clients in medically assisted rehabilitation 
No. of clients at 
31.12.1998  
No. of clients at 
31.12.2001 
No. of clients at 
31.12.2002 
No. of clients at 
31.08.2003 
173 1,501  1,984 2,285  
 
Evaluation of the treatment has started, on the basis of ordinary reporting and research 
projects. Very little has been published, however. A more systematic evaluation has started 
in the form of individual reports on each patient from the patient’s main therapist. This “status 
report” describes the client’s social situation at the time of reporting and the treatment 
administered (medication and psychosocial). The report also includes clinically observed 
drug use and the results of urine samples for the last month, the number of months the client 
is adjudged to have been drug-free, criminality, and suicide and overdose figures for the last 
year. The preliminary reports from the autumn of 2002 indicate no proven or stated use of 
opiates among 60-90% of the clients during the last month. 
It is too early to conclude on the effect of the treatment. So far, the information and studies 
indicate a significant reduction in overdose mortality. The patients are more able to 
cooperate on the treatment of other diseases. Most individuals experience a clear 
improvement in their social functioning and quality of life. Criminality is substantially reduced. 
Many still have problems with the continued use of drugs, especially benzodiazepines, and 
partly alcohol and cannabis. Trial projects have also been carried out with buprenorphin. A 
randomised study was carried out of 106 opiate addicts who were waiting to be admitted to 
the methadone programme in Oslo. Fifty-five received buprenorphin – 51 received a placebo 
over a 12-week period. The conclusion was that the waiting list patients benefited 
considerably from buprenorphin as a temporary treatment with respect to relapse, self-
reported use of narcotics and well-being. Nonetheless, the patients found it difficult to remain 
in treatment over time without some form of psychological support (Krook et al: Addiction 
2001). 
 
A research project with buprenorphin for young opiate addicts was initiated in March 2002, 
led by the Unit for Addiction Medicine at the University of Oslo in co-operation with 
psychiatric youth teams in five counties. Seventy-eight persons have been admitted to the 
project, which aims to evaluate whether or not the treatment can lead to freedom from 
opiates. The project will also evaluate the use of naltrexon to prevent relapses after 
completion of medically assisted treatment. Another project will examine the use of 
methadone in patients with psychoses and opioid dependence, while yet another project will 
examine the use of naltrexon implantates for those wishing a relapse prophylaxis following 
abstinence-oriented treatment. 
 
Training 
All the centres conduct extensive training of personnel in cooperating municipal health and 
social services centres. The Unit for Addiction Medicine has initiated courses for doctors in 
addiction medicine and maintenance treatment. Courses have been held in all the regions. 
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This treatment has also been incorporated into the curriculum for further training of social 
workers at several university colleges (Helge Waal, UIO).  
 
11.4 After-care and re-integration 
After-care and re-integration is a municipal responsibility described in the Social Services 
Act. After-care is otherwise the weakest link in the treatment chain. Follow-up of and the 
building of a network around individual clients is often poorly organised and can have a time 
horizon that is far too short to be able to counteract a relapse into renewed abuse and the 
drug milieus. Experience shows that life after completing treatment involves a unique set of 
problems requiring a different professional approach than that taken by other support 
services. Currently, there are too few support services using this as their starting point.  
Several institutions run their own systematic after-care schemes and provide after-care 
housing. One example is Stensløkka resource centre in Oslo. The institution admits clients of 
both genders and couples, primarily those who have completed treatment for their drug 
problems. The overall goal is to enable the users to make use of their intact and potential 
resources so that they, on completion of their stay, are capable of coping independently – 
without drug abuse – finding housing, work/education and a social network.  
The Idea Workshop is a unit of the Stensløkka Resource Centre. The facility is offered to 
former drug addicts. The idea workshop is based on a learning facilitation approach and is a 
social meeting place for people with a common background. It is an integration measure 
based on the participants' resources and leisure interests. The overriding goal of all the 
activities included in the measure is to contribute to the integration of the individual into 
"normal everyday life". 
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Chapter 12. Interventions in the criminal justice system  
Regulations, laws and the correctional services’ legal practice were described in chapter  2.2. 
   
12.1 Assistance to drug users in prison  
The control measures described in chapter 2.2 also have an important preventive effect in 
addition to their control aspect. More specifically, for several years the Correctional Service 
has offered sentencing alternatives that target the inmates’ drug problems and drug-related 
crime. During and after serving a prison sentence, inmates with a drug dependence problem 
are offered participation in a number of programmes. Such programmes include: 
 
· Contract sentences, alternative to serving sentences in prison pursuant to the Penal 
Code section 12 
· Drug-related influence programmes 
· Life mastery programmes 
· Establishment of networks 
· Probation groups 
· Work experience within the prison 
· Education 
· Leisure activities 
· Participation in the prison system's work-furlough programme and support 
programme after release.  
  
A majority of the Correctional Service’s measures are concerned with issues that directly or 
indirectly address the convicted person’s drug dependence. Over the last two years, 
Canadian drug mastery programmes, called "Drug Prevention Programmes in Prison" (RIF), 
have been organised in some prisons.  After release from prison these programmes will be 
followed up by the "My Choice" programme, which aims to reduce the likelihood of relapsing. 
  
Contract sentences aim to combat drug use among inmates. They are based on a contract 
between the inmate and the prison, whereby he/she agrees to refrain from drug use while 
serving his/her sentence. The contracts are entered into on an individual basis in ordinary 
prisons or in conjunction with being transferred to a contract wing or contract prison. 
Normally no other demands are made of the inmate with respect to participation in other 
rehabilitation measures apart from the requirement that he/she must abstain from using 
drugs. Contracts are also used in non-custodial schemes, which may include conditions and 
requirements concerning abstention from drug and alcohol use, drug checks, frequency of 
attendance, participation in educational programmes, training in everyday lifeskills, 
participation in discussion groups and efforts to plan for the future. 
  
The HIV/AIDS issue involves major challenges for the prison system. An important aim is to 
protect inmates and staff from HIV infection. There are intravenous drug users in prisons, 
and despite control measures, needles are sometimes used. In order to prevent the spread 
of disease through needle sharing among inmates, the Correctional Service, together with 
the Norwegian Health Inspectorate, has reviewed the scheme whereby chlorine is available 
for cleaning needles. There are no needle distribution programmes in Norwegian prisons. 
  
Substitution treatment is provided to inmates who have already begun such treatment, so 
that they can continue the treatment while serving their sentence. In principle, substitution 
treatment may also be commenced while a sentence is being served, provided that the 
inmate satisfies the admission criteria for the programme (Ministry of Justice). The registered 
number of inmates receiving substitution treatment has increased manifold and will continue 
to rise in the years to come. 
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12.2 Alternatives to prison 
The Execution of Sentences Act section 12 offers inmates with drug problems the 
opportunity of being transferred to a halfway house or other treatment institution. Emphasis is 
on the institution being able to offer a programme that meets the individual's needs. The law 
specifically requires that there must be compelling grounds for a convicted person to serve 
his/her entire sentence in an institution, i.e. the convicted person’s need for treatment must 
be so great that the entire sentence should be served in a treatment institution. In practice, 
this provision is used almost exclusively as an alternative to prison for drug users. 
  
The prison system does not have specific lists or approval schemes for relevant section 12 
institutions, but considers in each case whether an institution can offer a programme that 
suits the needs of the individual in question. An institution will only be able to admit a 
convicted person in need of treatment if his/her sentence can be served under secure 
conditions, so that the requirements for alternative service of sentence are met. Facilities that 
only offer care are generally not accepted as treatment institutions. Transfers can only be 
made to institutions in Norway. A total prohibition against the use of alcohol and other drugs 
will be imposed on the convicted person for the duration of his/her sentence. This prohibition 
is also applicable during periods of leave, recreational activities, etc. As a rule, the 
opportunity to serve a sentence in a treatment facility/ halfway house is not granted if the 
time remaining until expected release exceeds 12 months. 
  
The Pathfinder Project is a rehabilitation programme run in co-operation between the Oslo 
prison authority and the Tyrili Foundation, a rehabilitation facility. This alternative targets 
heavy drug users and currently has capacity for 18 clients annually. Participants undergo an 
8-month introductory and motivating phase in the "Pathfinder house" at Oslo Prison, after 
which they are transferred to serve their sentences under section 12 of the Execution of 
Sentences Act in the Tyrili Foundation's continuation treatment programme, which includes 
life and work training. 
  
Influence programmes aim at crime prevention. They are based on dealing with social and 
personal problems assumed to contribute to crime. Violence and vice groups and release 
groups are examples of influence programmes. 
  
The Drunk Driver Programme extends over one year and is an alternative to a custodial 
sentence.  
  
The Correctional Service cooperates with a number of organisations with humanitarian, 
religious, sporting, cultural or drug prevention goals. These make a major contribution 
through home visits and activity programmes that promote skills, improve self-esteem and 
integrate former criminals into active recreational milieus. The intention is to strengthen such 
cooperation, among other things by involving voluntary organisations more directly in 
planning while inmates are serving their sentences. Special emphasis will be put on network 
building and on establishing inmates in positive, drug-free milieus, already before their 
release (Ministry of Justice). 
  
12.3 Further training 
The Correctional Service, through its training centre, the Correctional Service of Norway Staff 
Academy (KRUS) initiates and organises training for personnel who work with drug-related 
treatment and control measures. 
  
In 2003, KRUS has implemented the web-based refresher course “Narko på nett” (“Drugs 
online”).  
It has also organised web-based training in Motivational Interviewing (MI) or change-focused 
advice, developed for persons with dependence problems. MI is one of the basic tools and 
NATIONAL REPORT 2003   -  SIRUS 
 63
an important method for use by contact officers and those involved in various influence 
programmes. 
For the last three years, training in drug programmes has been conducted by a Canadian 
instructor and twelve officers are trained annually for the implementation of programmes in 
non-custodial schemes or prisons. The Drunk Driver Programmes have gradually been 
extended to include the whole country, and are offered to persons convicted for very high 
blood alcohol content in connection with driving or for repeated drunken driving offences 
(Ministry of Justice). 
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Chapter 13. Quality Assurance 
At present there are no formal quality requirements for establishing programmes for drug 
users.  
 
New initiatives to raise the quality of preventive measures were discussed in chapters 9 a) 
and 9 d).  
 
The issue of quality and quality assurance of treatment programmes has been raised on 
several occasions. The Ministry of Social Affairs’ circular 1-1/93 on the Social Services Act 
etc. mentions quality requirements in several places. The circular is not very concrete, 
however, and the amended Act from 1998 states that “The King may issue regulations to 
further provide for quality requirements in treatment and rehabilitation programmes”, but no 
such quality regulations have been issued. Pursuant to the current regulations anyone is 
free, in principle, to establish such programmes, but their operation will depend on whether 
or not the public sector is willing to buy the services offered.  
 
Pursuant to the Social Services Act the County Governors are responsible for supervising 
institutions providing care and treatment for drug users. The purpose of such supervision is 
to ensure compliance with laws and regulations and that clients are offered proper treatment 
and care. Supervision shall focus on all matters of importance to the clients’ wellbeing, 
welfare and legal rights. The supervisory body must visit the institutions at least four times a 
year. At least two of these visits shall be without prior notice.  
 
The client registration tool, Addiction Severity Index (ASI), is used in treatment planning and 
research. The adapted European version (EuropASI) is, for instance, used as the main 
instrument in SIRUS’ cost benefit study. Various treatment groups in Norway now wish to 
use EuropASI and the youth version, European Adolescent Assessment (EuropADAD), for 
more extensive client registration, both in order to meet the requirement for more emphasis 
on individual treatment plans and in order to establish a basis for treatment evaluation. 
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PART IV  SELECTED ISSUES 
Chapter 14  Evaluation of Drugs National Strategies 
 
By Dag Rekve, Senior advisor, Ministry of Social Affairs 
 
14.1 Existence of evaluation 
The previous Action plan for reducing the use of alcohol and drugs (1998-2000) focused 
primarily on preventive efforts, but included a strengthening of municipal intervention 
programmes for users. The implementation of the plan as such was not subject to any 
separate evaluation. 
 
The Government’s Action plan against alcohol and drug problems for 2003-2005 (see 
chapter 1.1) includes close monitoring of developments for both alcohol and drug problems. 
The plan aims at developing a system for measuring the extent to which the main goals and 
sub-goals of the action plan are realised. The purpose of the system is to determine whether 
the measures that are implemented are in line with and help to realise defined goals and 
strategies, and to uncover problem areas and any needs for improvement. This requires that 
the goals are made operational, that indicators for goal attainment are developed and that 
the various measures in the area can be linked to these indicators and goals. The Ministry of 
Social Affairs has chief responsibility for the development of the follow-up system, but is 
expected to work in close collaboration with other ministries, subordinate agencies and other 
players in the field.   
 
The development of a system of this kind that is meaningful will be very demanding in terms 
of resources. It requires not only a good overview of available instruments and measures in 
the area and their effects, but also good development indicators at the overall level. 
Extensive data has been available in both these areas, some of which is adequately quality 
assured and systemised, while other data has been collected on a more random basis and 
remains unsystemised. Nevertheless, there are deficiencies in certain areas as regards 
indicators, particularly relating to registration of harm.  
 
These deficiencies have delayed the efforts to establish a follow-up system, first and 
foremost, perhaps, because the development of a sufficiently stringent system has proved 
very demanding in terms of resources. Few countries or agencies have developed this type 
of system, and those that have, spend a lot of resources on it, for instance the USA’s 
Performance Measure System which is managed by the ONCDP.  
 
14.2 Methodology of evaluation 
For the reasons mentioned in 14.1 the Government intends to start by drawing up a more 
intervention-oriented document, showing how the different measures included in the plan are 
to be followed up and by whom. It is a twofold system. New (project-like) interventions will be 
followed up through reporting pursuant to a fixed template, while current policy task will be 
followed up by means of the ordinary (existing) reporting tools.  
 
A system is being prepared for continuing with the goal and intervention structure of the 
Action plan. The Action plan defines a total of 124 measures. All of them are reflected in the 
follow-up system. The initiation and implementation of the measures will depend on several 
different sectors and administrative levels. Some of the measures are partially overlapping. 
Some are permanent, while others are concrete and for a limited period only.  
 
In order to improve the coordination of drugs and alcohol policy at ministerial level, an inter-
departmental working group has been established. Each of the ministries is responsible for 
following up measures linked to its own sector. However, the system will be used by all the 
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ministries in their follow-up. The Ministry of Social Affairs is responsible for coordinating the 
follow-up.  
 
Part I of the follow-up system will consist of collecting and systemising all the measures and 
clarifying the distribution of responsibility at ministerial level. Where responsibility is split 
between several ministries, or where several ministries have part responsibility, this will be 
made clear. Part I describes how the follow-up is planned, and what this means to those in 
charge of follow-up. The status of follow-up work is also included here.  Part II is a template 
for following up new measures or limited projects.  
 
The Ministry of Social Affairs has delegated a great deal of the responsibility for following up 
the Action plan to the Directorate of Health and Social Affairs.  This includes coordination in 
relation to the regional competence centres for drugs and alcohol issues, the National Police 
Directorate, the Norwegian Customs and Excise and the Learning Centre.  The Directorate of 
Health and Social Affairs will fulfil its share of the responsibility for follow-up by means of the 
ordinary reporting tools such as agency management meetings and annual reports. 
Additionally, the Directorate files reports using a fixed template for new measures and limited 
projects for which it is responsible. 
 
As regards measures expected to be implemented at the municipal level, it is considered 
expedient for the Ministry of Social Affairs to request the County Governors to collect status 
information. Follow-up of the municipalities is intended to ensure that locally implemented  
measures help to realise the strategic goals of the Action plan. Here, it is necessary to 
develop a set of indicators that adequately measure municipal activities in light of the Action 
plan’s objectives.  
 
As part of the Action plan the Directorate of Health and Social Affairs has been assigned the 
task of coordinating a pilot project for locally based prevention over three years in selected 
municipalities.  The model consists of a number of prevention strategies which are adapted 
to local needs and implemented concurrently.  New measures that are implemented shall be 
based on research and have a documented effect.  This pilot project will be evaluated by 
SIRUS. 
 
In the long term the aim is to develop a system capable of measuring the effect of the 
measures that are implemented in relation to the goals of the Action plan. The results of the 
follow-up will be incorporated into the annual statement by the Minister of Social Affairs on 
the alcohol and drug situation in Norway, starting in the spring of 2004. 
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Chapter 15. Cannabis problems in context: understanding increased treatment 
demand. 
 
By Martin Blindheim, editor of the journal ’rus & avhengighet’ (”alcohol/drugs and 
dependency”). 
 
15.1 Cannabis use in the general population 
Cannabis has been a part of all illegal use of drugs in Norway since the 1960s. Since then, 
after alcohol, cannabis has been the drug with most users. Police’s statistics show that there 
have been cannabis seizures throughout the country in recent years.  
 
Norway has several good data sets that show how the use of cannabis has evolved among 
young people. The most important is the annual questionnaire survey conducted by SIRUS. 
For a more detailed presentation and discussion of the data, see chapter2.2.2. In recent 
years almost 30% of young people in the 15-20 age group in Oslo state that they have tried 
cannabis at some time. At the national level the figure is just over 15%. These figures are 
generally confirmed by several other surveys iv . 
 
There is less reliable data on use by older age groups. A questionnaire survey on drugs and 
alcohol habits in a nationwide representative selection of people aged 15–64 was carried out 
in 1991 and 1999 (chapter2.2.1). The percentage that had ever tried cannabis increased 
from 9.6 to 15.4%v. In an opinion poll conducted for one of the newspapers in Oslo in 2003v i 
around one third of the respondents in the 30–39 age group stated that they had tried 
hashish.  
 
15.2 Demand for treatment for cannabis use 
a) Client registration data  
A system for the registration of client data from out-patient and in-patient treatment 
institutions in Norway is being developed (see chapter3.1). The data is so far incomplete. 
Data is not supplied by all institutions. Moreover, complete data sets are not collected for all 
clients. An important limitation in the data is that there is no registration of the type of drug 
problems for which the clients are admitted, only of the extent of their use of the different 
drugs.  
 
Data collected in 2001 show that 6% of the women and 9% of the men admitted to drug 
treatment programmes in Norway stated that cannabis had been the most frequently used 
drug in the six months before starting treatment (figures 12 and 13. The share has increased 
slightly for men in the period from 1998 to 2001, while it has remained stable for women. A 
few large institutions offering both in-patient and out-patient treatment have registered 
roughly the same proportions. We emphasise that these are aggregate data. Several 
requests and registered courses of treatment may therefore be attributable to one and the 
same client.  
 
                                                 
iv  The drug situation in Norway 2002. SIRUS 2003. 
v  The drug situation in Norway 2002. SIRUS 2003. 
vi Dagsavisen 6 Oct. 2003 
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Figure 12. Most Frequently used drug 1998-2001 
 
 
Source:  The Bergen Clinics Foundation 
 
 
Figure 13. Most Frequently used drug 1998-2001 
 
Source:  The Bergen Clinics Foundation 
 
Despite the limitations in the data, it can be assumed that only a small minority of the clients 
admitted to Norwegian treatment programmes have drug problems that can be primarily 
ascribed to the use of cannabis.  
 
 
b) A questionnaire survey 
In 2003, in an attempt to register the scope of specific cannabis problems encountered by 
the treatment services I sent a short questionnaire to 27 facilities containing questions 
relating to their experience of persons who needed treatment for problems with the use of 
cannabisvii. The facilities registered in SIRUS’ database (www.rustiltak.no) was used as the 
basis. It includes out-patient services, in-patient treatment and housing and care facilities. 
Seventeen facilities that can be regarded as more or less representative, responded. I also 
                                                 
vii Unpublished. 
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contacted the outreach services in the cities and large towns. This survey is an attempt to 
obtain a rough indication of how extensively treatment is requested by cannabis users and to 
register the views of employees in the treatment services on this matter. 
 
Both the out-patient facilities and outreach activities, which work mainly with users under the 
age of 30, state that they have clients who need help relating to their cannabis use. This 
applies to both men and women. A minority of these clients only use cannabis substances, 
however; cannabis is used in addition to a number of other drugs. The most common are 
alcohol, amphetamines, ecstasy and tranquilizers. A typical comment from a psychiatric 
youth team: ”The users present their other problems first; their use of ”hash” is often 
disclosed after some time.”  
 
In-patient institutions have the impression that the use of cannabis by clients is stable or 
slightly on the increase. Employees feel that many people have problems relating to the use 
of cannabis, but that such use nearly always takes place in combination with other drugs. 
One big treatment foundations states, for example: ”Nobody says that they have only used 
cannabis”. Another states: ”We have multiple drug abusers. They all start by using cannabis 
– then they extend their abuse.”  
 
c)  Substitution treatment 
In medically assisted rehabilitation, cannabis together with tranquilizers is often part of  
”additional abuse” of other drugs. The policy for dealing with this varies, but such use of 
drugs is incompatible with participation in medically assisted rehabilitation. This has proved 
difficult to enforce, however. Many of the facilities state that they ”therefore turn a blind eye 
to” (modest) use of other drugs and choose to focus on bettering the quality of life rather than 
on the client being drug-free. 
 
d) Relapse 
A large proportion of those who have undergone treatment, will after a shorter or longer 
period relapse into a situation in which their lives are marked by the use of drugs. Many 
relate how the relapse has been a process in which the drug user started with a moderate 
intake of alcohol and/or hashish and gradually lost control. Many after-care measures, 
therefore, systematically target the use of alcohol and cannabis in an apparently normalised 
life style. The users are always recommended to stay completely away from cannabis 
substances. 
 
e) Sources of referral 
The services come into contact with their clients by way of referrals from a broad range of 
agencies: the primary healthcare services, schools, social services, psychiatric services, the 
correctional service, parents and through user requests. We have no information as to 
whether those with specific cannabis problems are mostly referred by particular agencies.  
 
f) Reasons for treatment demand 
We have insufficient information to properly answer this question. 
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g) Profile of clients 
The limitations of the registered client data make it difficult to provide a more detailed 
description of the minority admitted to treatment primarily due to cannabis problems.  
 
The questionnaire (15.1.b) included two questions relating to client characteristics. The 
respondents replied that the youngest among those who used cannabis extensively have 
problems associated with “dropping out” of family, school and social contexts, while the older 
users have mental problems such as anxiety/ depressions and general antisocial behaviour. 
One of the facilities replied that “being high becomes a way of life, with personal, family and 
social problems as a consequence.” The existing data do not allow for a more 
comprehensive description of clients who use cannabis frequently.  
 
h) Changes in legislation 
There have been no changes in the legislation affecting cannabis or other illegal narcotic 
substances. All use, possession, procurement, production and sale of cannabis is still a 
criminal offence under the Penal Code and/or the Medicinal Products Act. Law enforcement 
is less strict today, however, than it was only a few years ago. Today’s sanctions are milder 
for possession/ import for own use than if the intent is sale/ profit. In practice small quantities 
of cannabis for own use are no longer subject to criminal proceedings.  
 
 
15.3 Prevalence of problematic cannabis use and patterns of problems 
a ) Prevalence of heavy use 
Norway has no existing generally accepted definition of ”problematic cannabis use”. Vague 
definitions linked to behaviour and to the part the drug “plays in the life of the user” have 
been suggested, but are not commonly used. “Habitual use” is a term often used, but which 
has not been clearly defined. In connection with SIRUS’ questionnaire surveys, ”regular use” 
was defined as more frequently than ten times in the course of the last six months. This type 
of definition says nothing about the extent of the problem, however.  
 
As regards Norway there are only grounds for saying something about the frequency of use. 
In the SIRUS surveys (young people aged15–20) 7–10% nationwide and approx. 15% in 
Oslo stated that they had used cannabis during the last 6 monthsviii while 3–4% stated that 
they had used it during the past month. Around 3% at the national level and around 7% in 
Oslo stated that they had used cannabis ten times or more in the last six months.  
SIRUS points out that ”there is reason to believe that young people who regularly use 
narcotic substances, be it cannabis or stronger substances, will be underrepresented in the 
surveys”ix. There are therefore grounds for suspecting that the actual percentages are higher. 
 
We have no surveys that provide any data about habitual use of cannabis in the adult 
population. Nevertheless, researchers have agreed on several occasions that the use of 
cannabis in Norway is mainly a youth phenomena. 
 
b) Cannabis and driving accidentsx 
Norway has no available statistics on the number of traffic accidents involving drivers who 
have used cannabis substances. The National Institute of Public Health’s department of 
forensic toxicology, which analyses blood samples for the police among others, has reported 
that in a 15-month period they registered a sixfold increase in the number of blood samples 
from drivers stopped by the police on suspicion of being under the influence of other drugs 
                                                 
viii Skretting, Astrid. Ungdom og rusmidler. The Directorate for the Prevention of Alcohol and Drug 
Problems, Oslo 2000. 
 
ix The Drug Situation in Norway 2002. SIRUS 2003. 
x Data from: Drug problems in Norway 2000. Ministry of Social Affairs 2000. 
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than alcohol. After alcohol, cannabis is the substance most frequently detected in such 
analyses. The number of samples testing positive for cannabis increased from 564 in 1990 to 
1,886 in 2002 (chapter3.4.1). 
 
c) Social problems related to cannabis 
In Norway there has been no research that demonstrates a causal relationship between the 
use of cannabis and social problems. Several studies demonstrate that there is a 
relationship, however, and possible explanations are discussed. 
 
The Young in Norway survey (Norwegian Social Research - NOVA), which analysed various 
aspects of young people’s life situation, including drugs and alcohol use, showed that 
extensive use of cannabis is linked to a high consumption of other drugs, criminal behaviour 
and problems at school and in the workplacexi.  
 
SIRUS’ questionnaire surveyxii shows more extensive use of cannabis among those living 
with only one or neither of their parents than among those living with both their parents. 
There is also a clear relationship between interrupted education and the use of cannabis at 
least once, and also between a feeling of satisfaction with one’s own life and the use of 
cannabis.  
 
d) Psychiatric problems related to cannabis use 
In Norway no figures are available as regards cannabis-triggered psychoses or other mental 
health problems.  The discussion on whether or not there is a relationship between the use of 
cannabis and the development of mental illnesses crops up at irregular intervals. The term 
cannabis psychoses has been launched in this context. In Norway, as in other countries, the 
professionals seem to agree that there is a correlation between mental problems and the use 
of cannabis, but opinions differ about possible causal relationships.  
 
e) Health problems related to cannabis 
No surveys are available in Norway that document specific health problems relating to the 
use of cannabis.  
 
15.4 Specific interventions for problematic cannabis use  
Among those who replied to the questionnaire ( 15.1.b), only three stated that they had tried 
out interventions for cannabis users. Very few respondents answered that they knew of 
others who had implemented such spec ific interventions. The lack of specific interventions 
for cannabis users is confirmed by searches on the internet, where the hits almost 
exclusively concern medical use of cannabis.  
 
Of particular interest, therefore, is a recently started cessation programme for cannabis users 
organised by the outreach service in Stavanger. This is described in more detail under a).  
 
Of the two other facilities that replied that they had experience of own measures, one 
psychiatric youth team reported that it had organised discussion groups for ”cannabis 
quitters” a few years ago. This measure was not described in detail, but reported to be 
”successful”.  
 
To the question of whether there is a need for treatment of cannabis problems, most facilities 
reply that they see an increasing need, but without stating any exact figures or supporting 
their statements in any way. Opinions differ as to whether the need should be met by 
                                                 
xi Pedersen, Willy: BitterSøtt, Universitetsforlaget, 1998. 
xii Skretting, Astrid. Ungdom og rusmidler. The Directorate for the Prevention of Alcohol and Drug 
Problems, Oslo 2000. 
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specially developed measures or whether it can be met by existing measures. Those who 
believe that new measures are required have proposed individual treatment and discussion 
groups using cognitive therapy, and group therapy using the same model as courses to wean 
smokers off nicotine. 
  
a) Smoking cessation for cannabis users 
In spring 2003, the outreach service in Stavanger carried out a pilot project aimed at young 
people who wished to stop using cannabis. The project has been thoroughly described.xiii 
The starting point for the project “Stop smoking course for hash smokers” was the statistic 
showing that a quarter of this group uses so much that it “will influence their lives in a 
negative direction.”  
Those in charge of the project say that “it proved difficult to find anyone at all in Norway with 
experience of group therapy in relation to cannabis. They therefore chose to develop a 
course based on Swedish material that was translated into Norwegianxiv.  
The target group for the course was “Young people who have expressed a desire to stop 
smoking hashish and who believed that they needed help to do so.” The goal of the course 
was to become drug-free “with a view to freeing the young people’s resources so that they 
would be able use their talents and abilities.” 
The methods employed consisted of discussion groups that focused on problems 
experienced by the participants themselves and the development of mastery strategies in 
relation to them. The discussions were combined with ear acupuncture using the NADA 
method, relaxation exercises and other means of fostering “wellbeing”. 
 
The course started with five participants and lasted for six weeks, with thrice-weekly 
meetings during the first weeks gradually decreasing to one meeting per week. Three of the 
participants completed the whole course, and all five participants have stated that they have 
reduced their cannabis use greatly or stopped completely. Those in charge of the project say 
that the participants themselves point out “that the success of the course is in large part due 
to them being part of a group” with discussions in which they could exchange experiences, 
receive support and backup with respect to how hard it was. 
 All the participants expressed great satisfaction with the wellbeing part of the course. All the 
participants will be contacted as part of a six-month evaluation “to register their general life 
situation and degree of freedom from drugs.”  
The outreach service’s summing up is that the project has been so successful that it intends 
to start a new course in October 2003 following the same model. The most important change 
will be to extend the course to eight weeks. Several other outreach services, in Bergen and 
Oslo among others, wish to copy this course. 
 
b) Schools  
Traditionally, schools in Norway have been an important arena for prevention of drugs and 
alcohol abuse and associated problems. For years, cannabis has been seen as a “gateway 
drug” to heavier use of illicit substances and schools have focused strongly on cannabis. 
Endeavours have been made, however, through the school counselling services to offer help 
to students who are in the process of developing problem behaviour rather than expel them. 
This work has not been systematically summarised, but our impression is that endeavours 
are made to view the students’ life situation as a whole rather than focusing exclusively on 
the use of specific drugs. 
 
c) Workplaces  
                                                 
xiii Hege Sundby and Zoila Santiago: Røykeavvenningskurs for hasjrøykere. Project report . Outreach 
service in Stavanger 2003. All quotes in this chapter are taken from a preliminary draft of the project 
report and are reproduced with the authors’ consent. 
xiv  Thomas Lundqvist: En guide for deg som vil slutte med hasj. The Borgerstad Clinic competence 
centre, 1999. 
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Through the work of the Tripartite Committee for the Prevention of Alcohol and Drug 
Problems in the Workplace (AKAN), Norway has a unique and recognised system for 
prevention and for providing assistance to employees who are in the process of developing 
problems relating to alcohol and drugs. As in schools, attempts are made to help and 
integrate employees with alcohol and drug problems instead of firing them, and focus is 
placed on their total life situation rather than on their abuse of drugs or alcohol. There are no 
good data showing the prevalence of alcohol and drug problems in Norwegian workplaces. 
Nor is the work of the Tripartite Committee for the Prevention of Alcohol and Drug Problems 
in the Workplace (AKAN) linked to specific intoxicants.  
 
15.5 Conclusions 
· Between a fifth and a quarter of young Norwegians aged 15-20 try cannabis 
substances at least once.  
· A smaller proportion of this age group (15-20) uses cannabis frequently, while only a 
small group develop habitual use. 
· For persons with an extensive consumption of illicit drugs, cannabis often constitutes 
an important element in their abuse.  
· Very few of those who avail themselves of facilities in the drugs field, have problems 
exclusively linked to the use of cannabis substances. 
· Experience of special interventions aimed at those with cannabis-related problems is 
highly limited.  
· Several facilities have expressed the opinion that such measures are required. 
 
Problem use of cannabis is overwhelmingly perceived as being part of a broader substance 
abuse problem which involves several substances. It is to some extent also perceived as 
being an expression of underlying mental problems. It is difficult to say whether this is an 
expression of the situation as it actually is or whether cannabis-related problems have been 
“overshadowed” by graver problems relating to harder drugs, and have therefore not been 
recognised and addressed through relevant interventions. 
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Chapter 16. Comorbidity 
 
By 
Tone Øiern, journalist for the professional journal ”rus & avhengighet”(alcohol/drugs and 
dependency);   
 
Reidun Evjen, head of department of the Tøyen branch of Medically Assisted Rehabilitation in 
Oslo; Knut Boe Kielland, general practitioner, supervising physician at the State clinic for drug 
addicts and advisor to the Eastern Norway competence centre. 
 
Comorbidity between intoxication and psychiatry has many different aspects. It may involve 
clients with serious mental problems such as schizophrenia or a bipolar disorder, where the 
concept of dual diagnosis is often used. Clients with very serious personality disorders also 
belong in this category. Comorbidity in this context may also include a number of 
alcohol/drug-abusing clients displaying a wide range of slightly less serious mental problems, 
anxiety and depression being their main symptoms. They may be marked by having grown 
up under difficult conditions, and some may also be marked by traumatic experiences in 
childhood and adolescence. Social abjectness and difficulties in utilising existing treatment 
facilities are often central characteristics. In the following description, we will take a relatively 
broad approach to various mental health problems in alcohol and drug abusers. 
 
The treatment statistics (Skutle & Iversen 2002, Iversen 2002) show that 26,000 courses of 
treatments for abuse of legal and illicit substances were carried out in Norway in 2000. In the 
Norwegian medication-free treatment the same methods are often employed regardless of 
which intoxicants the patient/ client has used. There are various treatments available to 
young people and adults, and there are a few treatments available only to women or only to 
men. The treatment statistics say nothing about the clients’ mental health problems or 
illnesses.  
 
A cross-sectional survey is carried out every five years in the mental healthcare sector on 
patients admitted to psychiatric wards. In 1994 the survey included 3,060 patientsxv. 
Approx.16% of these had a serious drug abuse problem (Norwegian Board of Health 2000). 
However, it is known from other surveys that registration of alcohol and drug abuse is often 
inadequate, so that it is reasonable to assume that a higher proportion of the psychiatric 
patients had substance abuse as an additional problem.  
 
 
16.1 Main diagnoses, prevalence 
In recent years a number of surveys have been carried on Norwegian abuser populations in 
order to study mental infirmity. These studies have involved alcohol or drug users who are 
undergoing some kind of treatment or other. The most thorough was the Alcohol/drug use 
and psychiatry survey (ROP) carried out by the Eastern Norway competence centre in 1997-
98. Two hundred and sixty clients who were either in out-patient treatment or in institutions 
for alcohol and drug problems were studied. Of these 
· 91% had lifetime experience of suffering from psychiatric complaints 
· 83% had suffered from anxiety 
· 44% had suffered from depression. 
 
                                                 
xv  In a corresponding cross-sectional survey from 1999, questions directly relating to alcohol 
and drug abuse were not asked.  
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 Only one single patient in this population had symptoms commensurate with schizophrenia, 
while 14% had schizotype personality disorders. In all, 72% had personality disorders, of 
which evasive and passive-aggressive were the most common. Thirty-one per cent had 
antisocial personality disorders, while 44% met the criteria for more than two personality 
disorders (Landheim et al 2000). The study also showed that a high proportion of the women 
(38%) satisfied the criteria for post-traumatic stress disorder (PTSD). The same applied to 
17% of the men. For most of the clients the psychiatric symptoms appeared to predate the 
alcohol or drug abuse (Bakken et al 2002). The survey shows a lower degree of social 
integration in family and working life than several other European and North American 
surveys of corresponding populations, which indicates that this is a very abject group of 
substance abusers.  
 
Both the ROP survey and other surveys in Norway show that a high proportion of drug users 
have had pretty massive family problems, during their upbringing and in school. A survey of 
2,359 drug users undergoing treatment in 1992-93 showed that 70% had experienced 
learning and behavioural problems in schools, 38% had experienced bullying and 21% had 
received psychiatric treatment during childhood or adolescence (Lauritzen et al 1997). The 
survey was based on questions put to therapists, who stated that 57% of the clients currently 
had problems with depression and 56% with anxiety. Forty-three per cent had experienced 
life-threatening overdoses, and 33% had attempted suicide. The survey did not provide good 
information concerning personality disorders and psychoses. 
 
A survey carried out at a therapeutic community for alcohol and drug abusers in Oslo also 
found a high proportion (69%) with depression, measured using self-reporting methods (SCL 
90 and MCMI). Those who were still depressed on discharge had a considerably higher 
drop-out rate during the after-care phase than the other clients. These were assumed to be 
individuals with more pronounced depression who would probably benefit from a more 
specific antidepressant psychotherapeutic and medicinal treatment. The survey also 
demonstrated that clients with antisocial character traits coped better during the 12-month 
stay in the institution than more withdrawn, cautious and anxious clients. However, clients 
with pronounced antisocial traits often dropped out during the after-care phase. (Ravndal & 
Vaglum 1994). 
 
In 1999, the Norwegian Board of Health carried out a registration of the prevalence of 
patients with dual diagnoses in Norway and their treatment needs. The registration was 
based on clients known to have such problems, in the psychiatric sector, the alcohol and 
drugs sector and in the municipalities. The Norwegian Board of Health concluded that there 
were approx. 4,000 individuals in Norway at that time (9 per 10,000 of the population) who 
had both a serious psychiatric complaint and an extensive alcohol or drug abuse problem, 
and who needed treatment facilities over and above the existing ones. Roughly half of them 
primarily had alcohol problems. Of the 4,000 individuals, approx. 1,200 were thought to have 
schizophrenia-like psychoses or bipolar disorder, 800 had serious depression or anxiety or 
similar complaints with a very serious dysfunction, and approx. 1,700 had a serious 
personality disorder, most of which were of the emotional instability or dissocial type. A group 
of more than 300 persons with serious cognitive dysfunction, either in the form of mental 
disability or impairment of more selective cognitive skills, was also included. 
 
The above-mentioned surveys concern alcohol or drug users undergoing some form of 
treatment. Some reports are also available on clients not undergoing treatment. Naturally, 
these are less exact and consist of evaluations of problem loads in clients in various types of 
low-threshold facilities. Some were carried out at acute accommodation facilities for the 
homeless, others at low-threshold heath facilities for drug users. What they have in common 
is that they show a significant load of combined problems involving alcohol/drug abuse and 
psychiatric symptoms in these populations. These problems include schizophrenia, 
personality disorders, mental effects of traumas such as rape or other types of violence. 
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They also include mental health complaints that are closely related to the substance abuse 
itself (SINTEF Unimed 2003, Feltpleien 2001). 
  
16.2 The impact of comorbidity on services and staff 
With the exception of a few ambulant measures, housing facilities and specialised treatment 
units (chapter16.4), there are few examples of measures tailored to the needs of this type of 
comorbidity. These are patients in mental healthcare, particularly in acute facilities, out-
patient alcohol/drug or psychiatric services, in facilities provided by humanitarian charitable 
organisations (warm-up centres), low-threshold accommodation facilities (hostels) or in 
institutions run by the correctional services.  Because of the compound nature of the 
problems involved, they are also in receipt of services from many different agencies, both 
welfare and care facilities and specialised treatment facilities in the areas of alcohol/drug 
abuse and psychiatry. There is reason to assume that in Norway this patient group 
experiences that it meets with a somewhat inconsistent response.     
It has been decided that services that address the needs of those with dual diagnoses will be 
integrated in a comprehensive patient and intervention-based national plan that was 
instigated in 1999 and will run for eight years. Its goal is to expand both specialist and care 
services (Escalation plan for mental health (1999-2006) in 2003, proposed extended until 
2008). On the basis of the registration of the situation of dual diagnosis patients, the Ministry 
of Health has issued a guideline that “this group needs special services with special 
expertise, both in the form of separate in-patient facilities and out-patient follow-up.” Rather 
than establishing special projects, it will be most expedient in Norway to integrate new 
services with already existing facilities. Three or four integrated teams based on experience 
of ACT (Assertive Community Treatment), inspired by the New Hampshire model among 
others, are now being tested in the mental healthcare sector in Norway. 
In general, treatment evaluation shows that it is important that those who work with persons 
with dual diagnoses simultaneously address both the alcohol/drug abuse problems and the 
mental illness. More training is required in special attitudes and techniques adapted to clients 
with combined problems. Such programmes are in the process of being introduced in some 
places. 
 
Increased competence can be achieved in many ways, for instance by establishing a 
common training programme that will be able to ensure mutual exchange of experience 
between different professions. Systematic training of staff can also take place through 
practice periods in workplaces which have the competence required.  There are currently a 
number of short courses available on mental health problems and alcohol/drug abuse. 
However, there is no distinct speciality in the treatment of dual diagnoses in Norway at 
present. Nor is the treatment of alcohol/drug abuse a medical speciality. It is possible for 
those with university college qualifications to supplement their education by taking a two-year 
course of further training in substance abuse treatment or mental healthcare work. Both 
these educational courses include the treatment of mental health problems in combination 
with drug/alcohol dependency. Studies leading to a masters degree in mental health work 
are also planned and comorbidity will be part of the course of study. Courses in medicine 
relating to alcohol/drug abuse have also been initiated for doctors.  
 
Six of the seven regional competence centres are attached to clinical milieus and each 
centre has specialised in one area relating to drugs and alcohol. The Eastern Norway 
competence centre has “dual diagnosis” as its speciality field and it has carried out extensive 
registration of the mental health of clients seeking treatment for alcohol or drug abuse in two 
counties (chapter16.1). Various forms of knowledge and competence building around 
alcohol/drug abuse and psychiatry is being carried out in all five Norwegian health regions.  
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16.3. Service provision for persons with drug abuse and psychiatric complaints 
There are several reasons why persons with alcohol/drug abuse and psychiatric problems 
are difficult to reach with treatment. It is normal to attribute this to the patient’s situation, but 
the difficulties may also be due to poor interaction between the support services and the 
patient.  The fact that the local community, the treatment services and society as a whole 
lack understanding of the client’s assistance needs, for instance, may lead to such people 
being described as “lacking motivation”. Persons with dual diagnoses may have many 
reasons for feeling despondent and without any hope for the future. They have often had 
many negative encounters with the support services and may therefore resist new treatment.  
This may lead to them being blamed for a poor treatment result, which might equally well be 
the result of the helplessness of the support systems.  
The ordinary health services, both somatic and psychiatric, have generally proved unable to 
reach heavy substance abusers to a sufficient extent. This has led to the development during 
the last two years of low-threshold health services in the cities and large towns. The aim is 
partly to provide health services and partly to establish contact with the regular health 
services. Among other problems these patients have – and this is hardly peculiar to Norway 
– is the fact that they have poor networks of family and friends as well as poor education and 
work experience. Their contact with psychiatry is often characterised by brief admissions, 
often on a compulsory basis, but seldom for systematic long-term treatment. There are 
frequent interruptions in therapeutic relationships instead of continuity.  
A select committee appointed four years ago by the Ministry of Health and Social Affairs 
(Ministry of Health and Social Affairs 1999) concluded that persons with dual diagnosis 
problems often become clients of the alcohol and drugs services, even though the mental 
healthcare services would in many cases have been able to provide more adequate 
treatment. This may have to do with the fact that capacity considerations are often decisive 
with respect to where clients are offered treatment, rather than which treatment options 
would best suit the client.  
Employees in three low-threshold facilities and two rehabilitation centres in Oslo were 
interviewed about how persons with dual diagnoses for whom applications are submitted, are 
treated by the institutions (Bjøntegaard 2000). With one exception all the five facilities 
accepted dual diagnosis clients.  They regarded themselves as the system’s “losers” 
because there were great difficulties attached to getting others in the support services to 
assume further responsibility for this group. Funnelling the client from a low-threshold facility 
to treatment/rehabilitation was experienced as being very difficult. They felt that they could 
not provide adequate help themselves because they lacked competence, manning, time and 
other resources, because storing medicines and administering medication was outside the 
institution’s responsibility and because they had to take other persons in the facility’s target 
group into consideration.  
 
It was clearly the case previously that persons with dual diagnosis were often excluded from 
alcohol/drug abuse treatment because of their mental problems and from psychiatry because 
of their alcohol/drug problems.  This still happens but there may be grounds for believing that 
the efforts described here mean that it happens less often than before. Evaluations of 
individual patients, particularly of their mental health problems, are difficult to perform while 
the patient is intoxicated and also during the first period after they stop their substance 
abuse. It is important to be able to repeat the psychiatric evaluation during the course of 
treatment. 
Several regions have initiated specific measures aimed at reaching individuals who are in the 
process of developing schizophrenia as early as possible – since research indicates that 
early treatment can improve the prognosis. These projects show that many of the patients in 
question also have serious substance abuse problems. The projects have therefore 
emphasised integrating the treatment of these two problem areas (chapter16.4).  
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Another problem which is more pronounced in patients with comorbidity than in others, is the 
difficulty of obtaining and holding on to a place to live. There is a substantial need for 
supported housing for this group. How such houses can best be designed and manned is a 
matter still under discussion. There are plans to allocate funds for this purpose in the 
escalation plan for psychiatry, but whether the allocated funds will be adequate is uncertain. 
It is also uncertain whether the municipalities will place sufficient emphasis on the needs of 
the target group when distributing funds. 
 At least half of those serving prison sentences are assumed to have a drug-related history; 
they are serving short or long sentences for violation of drug laws (30%) or for crimes closely 
related to their drug abuse (20%). The treatment of psychiatric complaints during prison 
sentences has often proven difficult. Nor do most inmates receive meaningful treatment for 
their drug abuse. No good Norwegian study is available on mental health problems and drug 
use among inmates in Norwegian prisons, but many of the clients in prisons are clearly not 
unlike those in treatment institutions for drug abusers. The relapse rate is high among drug 
users who have served prison sentences, and there is increasing recognition of the fact that 
prison terms can contribute to a worsening of mental health problems and unfortunate 
patterns of behaviour.  
 
Norwegian legislative provisions relating to the treatment of those with alcohol and 
drug dependency problems 
 
The Mental Healthcare Act (section 3) authorises the use of compulsion in mental 
healthcare, in or outside institutions. This possibility can also be used for seriously mentally ill 
alcohol or drug abusers. This authority is most often used in very acute psychotic episodes, 
but it is possible to use it without special time limitation in the most serious cases. In general, 
compulsion is more often used for acute admissions to psychiatric institutions in Norway than 
in many other Western countries. Compulsion is more often used for committing mentally ill 
alcohol and drug abusers than other psychiatric patients (Norwegian Board of Health 2000a, 
annex 2).  
 
The Social Services Act (section 6.2) authorises the admission without consent of alcohol 
and drug abusers for stays of up to three months in institutions. It is a precondition that the 
client’s abuse seriously threatens his/her life or health. This section is relatively little used. 
The Mental Health Act is most frequently used in connection with alcohol and drug abusers 
with mental illnesses (normally psychosis).  
 
The Execution of Sentences Act  (section 12) allows for treatment in an institution during the 
serving of a prison sentence (section 12.1). This possibility is used, but only in a very small 
proportion of cases where alcohol and drug abusers are serving sentences. There is no 
reliable information as to whether it is more often used for mentally ill drug users than other 
users. All inmates in Norwegian prisons are offered medical examinations but it is uncertain 
whether this is sufficient to detect all cases of serious mental illnesses. Reports are available 
from some prisons concerning the extent of mental illness and drug abuse, but no systematic 
registration of this has been carried out.  
In Norway, there is a widespread understanding that drug users should serve their sentences 
in such a way as to facilitate treatment and follow-up, but treatment is not instigated by the 
correctional services. Only recently was a working committee appointed to evaluate the 
Penal Code’s authorisation of the use of compulsion in the treatment context, through the 
postponement or cancellation of sentences if a person becomes drug-free.  
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Voluntary treatment 
In the international context, Norway has one of the highest numbers of treatment places for 
alcohol and substance abusers and, traditionally, it has concentrated a lot of its resources on 
treating addicts in institutions, compared with the resources used by the municipalities on 
long-term help in clients’ local communities. 
 
Evaluating patients in Norwegian alcohol and drugs facilities for further help in mental 
healthcare necessitates cutting across administrative boundaries. Very many alcohol and 
drugs facilities report difficulties in getting specialists in mental healthcare to take 
responsibility for meeting the treatment needs of a patient group that requires specialist 
services from both sectors. The reform which entails including both alcohol/drug treatment 
and mental healthcare under the same regional health trusts, aims to improve cooperation 
between the specialist health services. Including these services under the same 
administrative level will give the alcohol/drug treatment services the same status as specialist 
health services on a par with the specialist psychiatric service. This will facilitate 
coordination. The specialist health services’ responsibility for the treatment of alcohol and 
drug abusers will be strengthened, thus improving the services provided for this group.  
 
It is emphasised that an interdisciplinary approach is a precondition for achieving the goals in 
the escalation plan for mental health. Competence in the social work field and a knowledge 
of network building are seen as necessary requirements for helping clients to manage on 
their own in supported housing and helping with supported employment. The municipalities 
are responsible for care services, while specialist responsibility rests with the state. Because 
many of these persons need both treatment and care, i.e. simultaneous help from both 
specialist services and the municipality, it is very probable that clients will simply be passed 
form one service to the other. In order for the cooperation to work on the user’s terms, it is 
important that professional care work is given the same status as other approaches. The 
number of out-patient, and a in a few cases in-patient, facilities treating patients with 
comorbidity is increasing. Developments have also taken place in alcohol/drug treatment 
measures through the addition of psychiatric competence. 
 
Specialised teams 
There are 34 specialised teams for adolescents and young adults with drug dependency 
problems, the Psychiatric Youth Teams (PUT). The teams include professionals such as 
doctors, psychiatrists, social workers and child care workers and offer consultations on an 
out-patient basis. 
In a survey the teams themselves estimated that 30% of their clients suffer from serious 
mental problems in addition to substance abuse. Nearly one in three clients break off 
treatment and one in three fail to attend treatment appointments. A publication about the 
needs of persons with dual diagnosis today states that “Therapeutic services are of little 
value if you do not know where you are going to sleep at night or how you are going to get 
your next meal” (Bratteteig, 2001). The Ministry of Health and Social Affairs wants to give 
priority to persons with dual diagnosis and to redirect resources from PUT to special 
measures for drug users with serious mental illnesses, (Storting Report 25, 1996-97), and 
proposed the setting up of “special services for young people with alcohol and drug problems 
and mental illnesses in each county. These could take the form of one or more “Psychiatric 
youth teams” attached to the central hospitals’ departments for alcohol and substance 
abuse-related psychiatry or to one or more district psychiatric centre in each county. The 
teams should work externally and take an outreach approach. Any reorganisation of the 
services should be carried out in such a way that existing competence is preserved.” 
 
Three to four teams have been established to test models for ambulant/ outreach services 
aimed at persons over the age of 18 with a dual diagnosis. They consist of inter-disciplinary 
units that together have high competence in the comorbidity field and where one and the 
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same group of therapists will be able to deal with both alcohol and drug abuse and mental 
illness.   
 
The department of alcohol/drugs-related psychiatry at the Psychiatric Clinic at Rogaland 
central hospital has set up two ambulant groupsxv i each attached to a psychiatric youth team 
intended to reach patients with abuse problems and mental illness and who do not avail 
themselves of, or drop out of, existing services.  The team in Sandnes has had 44 patients 
up to October 2003, most of them between the ages of 25 and 35. Twenty-four of the 
patients have psychosis problems. Thirty-one of them do not have satisfactory housing 
arrangements. An evaluation of the project is planned.    
 
In Oslo the project  Alcohol/drug use and psychiatry (ROP) is attached to a district psychiatric 
centre.  The project, which started in January 2001, will run for five years and is staffed by 
psychologists, psychiatric nurses, social workers and psychiatrists.  The target group 
consists of patients from Oslo who have difficulty, or are completely incapable of, availing 
themselves of the general health and social services. They must have serious drug 
dependency problems of at least two years’ duration, and there must be grounds for 
assuming that they also suffer from serious mental health symptoms such as schizophrenia, 
schizotype disorders, bipolar disorder or serious personality disorders. The project will offer 
follow-up for up to two years. The team will be very accessible. It will be possible to 
contact/visit the patients at home, in hostels, on the street or in prison. The focus will be on 
basic needs such as housing, work, social benefits and social relations. The project will be 
evaluated through interviews with a selection of patients and collaborating partners, by 
systematising diagnostic material.  
 
Up to summer 2003, 64 patients had been helped by the project and 25 had completed 
treatment and been discharged.  Sixty per cent have no fixed abode. Their average age is 
34. Twenty-five of them are opiate users, while most (50%) are multiple users. Twenty-one of 
the patients are receiving treatment using methadone or Subutex, and these patients appear 
to be benefiting more from the project than those not receiving substitution treatment. It is 
estimated that 49% have psychotic illnesses, 14% affective disorders and 25% personality 
disorders or other mental problems. Among those with psychoses, many have more than one 
additional diagnoses. (Øverås 2003).  The goal is to establish a parallel service to the 
existing one, but that contact with the regular help agencies will be established and 
maintained during the period the patient is part of the project. The project has generated 
cooperation on depot medication pursuant to decisions to use compulsion, where the 
medical responsibility lies outside the team.  
 
In-patient treatment 
There are 6-7 in-patient treatment facilities in the alcohol/drugs and psychiatry field that 
include persons with dual diagnosis problems in their target group (Evjen 2003). The 
treatment facilities either have expertise on dual diagnoses themselves or they bring in 
expertise for guidance purposes. So far, there has been no research into or evaluation of 
these facilities.  
 
One survey of a hierarchic therapeutic community in Norway (Ravndal & Vaglum 1994) 
showed that patients with antisocial personality traits coped fairly well during the actual stay 
in the institution, but that they had a high drop-out rate in the after-care phase. It was 
concluded that the situation following discharge should probably include structural elements 
and limits similar to those applying during the stay in the institution. 
 
                                                 
xv i Cf. The Ministry and Health and Social Affairs’ circular 1 – 36/2001. 
NATIONAL REPORT 2003   -  SIRUS 
 81
Medically assisted treatment  
Treatment of opiate addicts using methadone was initiated in Norway in 1998. A three-year 
trial project, the Methadone Project in Oslo (MIO), tried out in advance a model that included 
close follow-up, control and active rehabilitation in addition to medical treatment. The 
evaluation showed that anxiety and depression were widespread among the patients. These 
problems improved only slightly during the project period. The evaluation concluded that 
treatment specifically aimed at the mental health problems is essential. It was also the case 
that those with antisocial personality disorders completed the programme as successfully as 
those without such problems. This reinforces the supposition that for clients with such 
personality disorders, stringent rules, control and predictability - as found in the Norwegian 
model - have a positive effect. 
A research project on the use of substitution treatment for patients with schizophrenia and 
opiate abuse is in the start-up phase. The project will be carried out by the Section for clinical 
drug problems at the University of Oslo and will initially include 40 patients with medium to 
serious opiate abuse and schizophrenia.  The aim is to test the use of substitution treatment, 
which will be administered by a hospital department in the initial phase and subsequently by 
the district psychiatric centres. Among other things, the study will evaluate how well 
psychiatric treatment works for these patients. Extensive diagnostic examinations will be 
performed prior to inclusion and after two to three years. A questionnaire survey will also be 
carried out into the incidence of psychosis and opiate dependency in Oslo. 
 
16.4 Examples of best practice and recommendations for future policy 
Persons with dual diagnosis often have negative experiences of treatment. Establishing good 
relations with helpers in the social and health services takes a long time in itself.  Many in the 
target group have good relations with street-level facilities and low-threshold institutions that 
see it as their duty to cover their most basic needs, such as accommodation, food and 
keeping warm. 
It may be necessary to link these services to specialist services in order to create the 
required alliances.  
 
New organisation of services 
The examples in chapter16.3 provide experience of the effect of different programmes or 
individual interventions. Since the Norwegian policy aims to prevent persons with co-
morbidity from being excluded from the general services, we will include an example where a 
local community has organised its services in such a way that user influence and an 
integrated approach are central elements. The example is from a small municipality in 
Northern Norway.  
 
“The Øksnes project” 
 Øksnes municipality set up a Council for local psychiatry with users in the majority in 1997. 
The Council evaluates existing services and proposes measures relating to the services 
provided in the fields of alcohol and drug care and mental healthcare.   
 
A survey showed that 16 persons with compound psychiatric and alcohol/drug problems fell 
outside the services offered. They were constantly passed between the municipal help 
services, the psychiatric hospital, the clinic for drug and alcohol problems and other mental 
healthcare services. The doctors in the municipality had a heavy workload relating to the fact 
that drug use in this group was out of control.  Contact with the patients was characterised by 
acute emergency solutions involving short compulsory admissions to institutions requiring 
transport by plane or taxi/ambulance. The consultant for drug and alcohol problems, the 
psychiatric health worker, doctor and milieu therapist in the users’ arena have been formed 
into a professional team, without barriers and appointments, with responsibility for social 
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work and health measures. The team is physically accessible between 8:00 and 22:00, and 
by phone at night and at weekends.  
 
The premises used by the professional team, the “Meeting place”, is rented by the users. Up 
to 30 users come here daily. Various self-help groups have been set up and they help each 
other with practical tasks. For many of them this “haven” is a first step out of an isolated 
existence. It will be developed in cooperation with users, and with genuine user participation. 
The users will be able to influence what happens to both individuals and the group, but 
families and other involved persons will also be taken into consideration.  
Through cooperation with the local press, among others, a lot of effort was put into changing 
attitudes in the community, and the media monitored how user participation was put into 
practice. There was some resistance among staff to introducing a more accessible and 
flexible system in which those providing the services had to work more irregular hours than 
before.  
 
Today, the team also includes a representative of local labour market enterprises. Staff in 
non-municipal positions (the Team for adult psychiatry and the Team for child and youth 
psychiatry) now have regular working hours in the municipality. Integrated into the municipal 
services, they are thus part of preventive efforts instead of being brought in on an emergency 
basis as they were previously. Municipal employees receive continuous guidance and 
updating. The evaluation of the users is done while they are in their home environment.  
 
The “Meeting place” triggered a need for help, day and night.  During the Meeting place’s first 
year the project staff were very much in demand, but this fell off as time passed. The users 
stated that housing was problem number one. Good housing solutions have been the key to 
reaching this user group with other forms of help. Efforts have also been put into adapting 
workplaces, in cooperation with a local labour market enterprise among others.  
This is an important part of the project that provides relief for the specialists and that can be 
used “constructively” instead of just meeting a need for acute treatment.  The number of 
acute and compulsory psychiatric admissions has fallen sharply. Control of the use of 
medication has improved for the group with compound problems. The evaluation of the 
project showed that the target group’s situation had improved and that the public sector has 
“saved” the cost of hospital admissions, social security and welfare benefits (Foss 2000). 
 
Case management 
There is a need in Norway to coordinate services provided under different Acts and to adapt 
different local services and treatment measures. Various case-management models are 
being developed in work with psychiatric patients, including “Coordination of Psychosocial 
Work” (CPS) for the follow-up of patients with persistent and serious mental illnesses. The 
method consists of drawing up and implementing an action plan in cooperation with the user, 
which the coordinator uses to follow him/her up over time. Providing guidance for all those 
involved and ensuring organisational support in the existing services are central elements. 
CPS is not intended to replace traditional treatment. However, coordination often uncovers 
unrecognised treatment needs that are unknown to the specialist services. 
 
CPS will alternate between user-oriented rehabilitation and care work and work on adapting 
the network of interventions. A few of the users in the trial project had dual diagnoses. The 
CPS model works on the assumption that users will manage to attend appointments. This 
was a limitation in work with this group. The group that developed the CPS model in Norway 
has drawn attention to some experiences (Evjen 2003) involving users with particularly 
compound problems, as is often the case with dual diagnoses:  
 
· The personal coordinator must take an outreach approach and be accessible to a high 
degree. Systems should be developed whereby it is possible to alternate between 
counselling, treatment, care and rehabilitation according to the user’s needs. Treatment – 
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with cure as its goal – should only be included as one of several strategic options, that 
can be used for limited periods if expedient.   
· Emphasis on building good alliances. One should, for instance, drop the demand for 
urine sample controls if this creates mistrust and prevents the development of good 
relations.  
· Needs-based, not crisis-based follow-up.  
· Individual adaptation, matching different treatment methods to the user’s different needs.  
· Broaden the understanding of what constitutes the goal of the work – be it improvement 
of symptoms, reducing the experience of stress or easing the situation for the user’s 
family.  
· Register the benefits of one’s efforts. Increase understanding for “measuring” the results 
of interventions.  
· Pay great attention to the risk of a relapse of symptoms – which for this target group will 
often have major consequences.  
· Work systematically on preventing crises in individual users, be alert with respect to a 
deterioration of symptoms and initiate solution-oriented discussions. “What have I done 
previously in corresponding situations?” 
· Planned interventions must appeal to the user’s real needs. When “getting high” is an 
important part of the user’s life, interventions cannot be based on full freedom from 
intoxicants. 
 
The possibilities of evaluating interventions aimed at the co-morbidity group are limited. In 
order to measure the effect of interventions, it is necessary to carry out initial evaluations or 
diagnoses of persons who are the subject of interventions and then repeat them after the 
intervention. Only after stabilisation has taken place will it be possible to tell whether the 
person has an enduring mental health problem or whether it is drug-triggered, i.e. is a 
consequence of the abuse. One major challenge is to base the intervention firmly on the 
user’s needs and not on the existing services that established facilities can offer. Changes 
must also be made at the societal and system level where attitudes, theories and methods 
need to be changed so that the services do not exclude “difficult” groups of this type and so 
that they feel that they have sufficient “dual competence” or “cross competence”.  
 
Treatment adapted to different patient groups 
A study has been carried out summarising the treatment of clients with both alcohol/drug 
abuse problems and psychopathology based on the findings from six different Norwegian 
treatment studies carried out during the period 1967-1990 that showed a high incidence of 
mental illnesses, mostly personality disorders, anxiety and depression among patients 
(Vaglum 1996). One conclusion of this treatment study was that aggressive, impulsive 
behaviour was best treated by confrontational, structured group therapy combined with family 
therapy. Patients who were depressed or anxious benefited more from individual 
psychotherapy and supportive group therapy.  
 
Early intervention 
The project, Early Intervention in Psychotic Disorders in Rogaland aims to reach young 
people from as early as the age of 15, in order to start the treatment of psychotic conditions 
early on, based on recognition of the fact that the longer the psychosis remains untreated, 
the easier it will manifest itself. One method is the establishment of a discovery team. The 
team will provide follow-up lasting at least five years. The project started in 1997 and has had 
600 patients. Thirty per cent of those reached by the project, abuse alcohol/drugs as well 
having psychosis problems. The proportion with dual diagnosis is greater than in previous 
Norwegian surveys. One reason may be that the  project searches so thoroughly for patients 
and registers both symptoms in detail.  
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The project’s experience is that many of the alcohol/drug abusers show significant 
improvement when they receive treatment for their psychoses. It appears that the need to 
“get high” thereby decreases. So far, too little is known to be able to decide whether 
psychosis or near psychosis in this group is triggered by substance abuse or whether these 
conditions could have been prevented if the patient had not used drugs.  
 
Recommendations for future policy for the area 
 
· Integrated rather than isolated help. The treatment must be directed simultaneously at 
the alcohol/drug abuse and the mental illness. 
· The capacity to intervene early should be increased. 
· The therapeutic teams should develop special treatment methods designed for dual 
diagnosis patients. 
· The therapists must reach out to the clients, understand them on their own terms and find 
an approach that suits the patient.  
· Concrete help must be available in the client’s local community. A secure framework 
must be created so that the client can be helped to achieve better control of his/her 
alcohol/drug use and psychiatric symptoms.  
· The services must comprise comprehensive rehabilitation that includes the establishment 
of a secure housing situation, stabilisation of the client’s finances, family support, 
vocational training, crisis measures and stress management. 
· The possibilities for admission to a psychiatric in-patient department must be improved. 
· Medical treatment must be part of the programme. 
· Follow-up responsibility must be expected to last for several years. 
· The treatment programmes/therapists must build good alliances with the clients and 
focus on the successful formation of attachments to private and pubic networks.   
 
In light of the Norwegian Board of Health’s studies of the need for specialised treatment 
facilities for those alcohol/drug abusers with the most serious mental illnesses, the Ministry of 
Health (the Ministry of Health and Social Affairs 2001) recommends the establishment of an 
ambulant team that can reach out to and follow up patients at home as required, and 
“psychiatric youth teams” that work externally and on an outreach basis.  It is possible to find, 
both in the trial projects with ambulant teams and in the alcohol/drugs sector, good 
Norwegian examples that give grounds for believing that therapists who are able to spend 
enough time on cases often case succeed with treatment on a voluntary basis.  
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Figure 1  Percentage of young people aged 15-20 in Norway who report having used 
cannabis, ever and during the last six months, 1986-2003. 
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used cannabis, ever and during the last six months, 1968-2003 (three year 
sliding average). 
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Figure 4  Percentage of young people aged 15-20 in Oslo who have ever used different 
narcotic substances, 1970-2003 (three-year sliding average). 
Figure 5 Percentage of boys and girls who state that they have ever used cannabis 
(ESPAD). 
Figure 6  Percentage of boys and girls who have used cannabis during the last 12 
months (ESPAD) 
Figure 7  Percentage of boys and girls who state that they have used cannabis during 
the last 30 days (ESPAD). 
Figure 8  Drugs detected in correctional service cases. 
Figure 9   Methadone-related deaths in Norway 1991-2001. 
Figure 10   Number of traffic cases investigated by SRI/NIPH in 1990-2002, in which 
being under the influence of alcohol or other intoxicants was suspected. 
Figure 11 Number of drug seizures 1995 - 2002. 
Figure 12  Most frequently used drug 1998-2001 women 
Figure 13  Most frequently used drug 1998-2001 men 
 
 
Table 1 Registered requests for and initiated  treatment. 
Table 2  Drug-related deaths. Total number of deaths and broken down by gender.  
Figures from NCIS and SSB (underlying cause of death). 
Table 3   Proportion of intravenous drug users among persons infected by HIV or AIDS  
showing risk behaviour in the form of injecting use, by year of diagnosis. 
Table 4 Detection of various narcotic substances in traffic cases investigated by 
SRI/NIPH in 1990-2002. 
Table 5 No. of reported and investigated drug offences. 
Table 6 Number of persons charged with drug crimes. 
Table 7 Number of seizures 2000 – 2002  broken down by the most common 
substances. 
Table 8  Prices for some drugs in Oslo (January 2003). 
Table 9  Number of clients in medically assisted rehabilitation. 
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Abbreviations 
 
Abbreviations for Norwegian institutions used in this report.:   
 
AKAN   The Norwegian Tripartite Committee for the Prevention of Alcohol and Drug 
Problems in the Workplace 
NCIS  The National Criminal Investigation Service 
NIPH   Norwegian Institute of Public Health 
SIRUS  Norwegian Institute for Alcohol and Drug Research 
SSB  National Bureau of Statistics 
